ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001297.1|WS9326_1 # 49 # 891 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.686	BGC0001297.1|WS9326_1 	49	891	-	Loose	500	100.908	tetB(58)	32.02	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGTCGCCGAGGCCGGTACACCCTTGCGGACACCACCCGTGCGGCGCGACGGCACGACCGCCCAGTGGGGCACCAGCGGGCTCATCACGCAGACCGCCGCGCTCACCGGTCGCTCGCTGCGCCCCTACCTGAACGCCGGCGTCATCATCGTCACGTTCGTCGAACCCCTCGTCATGCTGCTGATGTTCGCCGGCGTGCTGAAGGTGCTCGGCGAGGCACCGGGCATGTCCAAGGAGATGGCCTACATCGACGGCCTGGCCCCCGCCATCATGATCATCACGGCGGTCGCCGCCGGCGCCCAGGCGGGCAACGGCCTCATCAACGACCTGCGCAACGAGGTCATCACCCGCTTCCACACGCTGCCCATCAACCGGTTCAGCGTGCTGCTGGCGCGCAGCTTCGCCGACGCCGCCCGCTCGCTCTACCAGCTGATCGCCGTGGCCGTACTGGCCGCGGTCATCTTCGGTTTCTCGCCACCCGGCGGCATCCTCGGCGTGCTGGGCGCGATCCTCATGAGCCTGCTCGTCGGCTGGTCGATGAGCTGGATCTTCATCATGATGGCGGCGCTGATGCGCAACGGCGACGTGCTGCGCATGATCACCACGCTGCTCACCTTCCCGCTGCTGTTCGCCTCCAACGCCTTCGTGCCGCCGGAGTCGATGCCGACCGGGCTGCGCGTGATCGCCCAGGCCAACCCGATCTCGTACGCCAACGACGCCGTGCGCGCCATGGTCGCCGGGAACGTCACCGTGATGGAGCTGGTCACGACCGTCGCGGTCTGCCTGGCCCTGGTGTGCGTGTGCGCCCCGATCTCCAAGCGCTCGTTCCGGGTGCTGTGA	MTVAEAGTPLRTPPVRRDGTTAQWGTSGLITQTAALTGRSLRPYLNAGVIIVTFVEPLVMLLMFAGVLKVLGEAPGMSKEMAYIDGLAPAIMIITAVAAGAQAGNGLINDLRNEVITRFHTLPINRFSVLLARSFADAARSLYQLIAVAVLAAVIFGFSPPGGILGVLGAILMSLLVGWSMSWIFIMMAALMRNGDVLRMITTLLTFPLLFASNAFVPPESMPTGLRVIAQANPISYANDAVRAMVAGNVTVMELVTTVAVCLALVCVCAPISKRSFRVL	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	103.32	gnl|BL_ORD_ID|4708|hsp_num:0	2518			141	801	tetracycline
BGC0001297.1|WS9326_2 # 929 # 1885 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.706	BGC0001297.1|WS9326_2 	929	1885	-	Loose	600	282.337	oleC	49.03	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGCCAATCCCATGATTGAGGCAATCGACGTCACAAAGTCGTTCGGTGACGTCACCGCGCTGAACGGTGTGAACGTCTCGGTTCCCGAGGGGTCGATCCACGGCTTGCTCGGCCACAACGGCGCCGGCAAGACGACCCTGGTCCACATCCTGTCCACGCTGCTGGAACCGAGCACCGGCACCGCGCGGATCTGCGGCCTGGACGTGACCCGGGACGCCCAGGACGTGCGCCGCCGCATCGGCCTGACCGGCCAGTTCGCCTCCGTGGACGAGCAGTTGTCCGGGCGCGAGAACCTGACCCTGATCGCCCGCCTGCTCGGCGCGAGCAGGCGGCAGGCGCTCTCCCGCGCCGACGAACTGCTGGAGCTGTTCGAGCTGACCGACGCGGCCAAGCGCCCGGCCTCCACCTACTCGGGCGGCATGCGCAGGCGGCTGGACATCTCGGCGAGCCTCGTCGGCTCGCCGCAGGTCATCTTCCTCGACGAGCCCACCACCGGTCTGGACCCCAACTCCCGGATCGCCGTGTGGGAGGTCATCGAGCGGCTCGCCAAGGACGGCGTCTCGGTGCTGCTCACCACCCAGTACCTGGAGGAGGCCGACCGGCTCTGCGAGCGGATCACCCTGCTCTCCAAGGGCTCGATCGTCGCCGAGGGCACGCCCACCGAGCTCAAGGGCGCCGTCGGCCAGCGCATGGTGAACGTGACACTGTCCGCCGAGTCGCAGGTGCCGGGCGCGCTGCGCGCCCTGGAGGCCGAGGGCTTCCGGCCCACCCTCGCGCAGGACTCCTCGACCGCCCTCGGTGTGCCCGTGACCGCCTCCGCCGACCTGGCGGTCGTGGTGCGCGCGCTGAACGAGGCGCACACCGACATCGCCGAACTCGGCTTCTCCGAACCGACCCTGGACGACGTCTATCTCCGGCTCACCCACGAGCCCGCCGCGACGCCGGTGCCCGCGTGA	MANPMIEAIDVTKSFGDVTALNGVNVSVPEGSIHGLLGHNGAGKTTLVHILSTLLEPSTGTARICGLDVTRDAQDVRRRIGLTGQFASVDEQLSGRENLTLIARLLGASRRQALSRADELLELFELTDAAKRPASTYSGGMRRRLDISASLVGSPQVIFLDEPTTGLDPNSRIAVWEVIERLAKDGVSVLLTTQYLEEADRLCERITLLSKGSIVAEGTPTELKGAVGQRMVNVTLSAESQVPGALRALEAEGFRPTLAQDSSTALGVPVTASADLAVVVRALNEAHTDIAELGFSEPTLDDVYLRLTHEPAATPVPA	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	97.85	gnl|BL_ORD_ID|2050|hsp_num:0	2264			15	939	oleandomycin
BGC0001297.1|WS9326_3 # 2525 # 3271 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.664	BGC0001297.1|WS9326_3 	2525	3271	-	Loose	450	53.9138	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	27.73	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGACGGAGAACACAGCGCCGGTCGCCCTGGTCAGCGGCGGCTCGCGCGGGATCGGCCGCGCCGTGGTCCTGCGGCTCGCGGCCGAGGGATACGACGTCTCCTTCTGCTACCAGTCCAACGAGCAGGCCGCGCTGGAACTGGAGAAGGAGGCCGGCGAACTCGGCCGGCGGGCCCTCGCCGTGCGCGTCGACGTCACCGACGCCGCCTCGGTCCGCGACTGGGTCACCCGCACCGAGTCCGAACTCGGCCCGGTCGACGTGGCGGTCAGCTCGGCCGGCATCACCCGCGACAACCCGCTGGTCCTGATGTCCGACGAGGACTGGCACAGCGTCGTGGACACCAACCTCGACGGCGTCTACCACGTGTGCCGCGCCGTGATATTCGAAATGATGAAGCGCAAATCCGGCACGATCATCAATATCTCGTCGATCGCCGGTGTGTACGGAAACGCCACCCAGGCCAACTACTCGGCCTCCAAGGCGGGCATCATCGGATTCTCCAAGGCGCTCGCCAAAGAGGTCGGTCGATACAACATCAGGGCCAATGTGGTCGCGCCGGGATTCATCGAGACCGATATGACGGCCGAACTCGCCGAGAAGGTCAAGAAGGACGCCGCGAAGAACATTCCGCTGCGCCGTTTCGGACAGGCCGAGGAAGTGGCGGACCTCGTCGCCTTCCTGGCGAGCGAGCGGGCCGCCTACATCACCGGATCGGTCCTCCAGATCGACGGCGGCCTGACGGTCTGA	MTENTAPVALVSGGSRGIGRAVVLRLAAEGYDVSFCYQSNEQAALELEKEAGELGRRALAVRVDVTDAASVRDWVTRTESELGPVDVAVSSAGITRDNPLVLMSDEDWHSVVDTNLDGVYHVCRAVIFEMMKRKSGTIINISSIAGVYGNATQANYSASKAGIIGFSKALAKEVGRYNIRANVVAPGFIETDMTAELAEKVKKDAAKNIPLRRFGQAEEVADLVAFLASERAAYITGSVLQIDGGLTV	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	94.66	gnl|BL_ORD_ID|4712|hsp_num:0	2666			90	759	triclosan
BGC0001297.1|WS9326_5 # 3818 # 4219 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.759	BGC0001297.1|WS9326_5 	3818	4219	-	Loose	500	25.0238	OXA-198	32.26	3001805	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACCGGCACCGTCCTGGCCGCCGCGCGGCCGGTGCGCGGACCCGCCCACGACGAGGACTCCGGGGCGTGGACGGCCGGCTTCACGGTGACGATCACCGAGGACGAGCCCGTCTTCGCCGGCCACTACCCGGACTTCCCGATCTTCCCCGGCGTCTGCGTGATGGAGTGCGTGCGCCGCGCCGCGGAGTCCGCCGCGCCGCCGGTCACCGGCGGACTGCGGCTGGCCGCCGTCGAGTCCACCCGGTTCCTCTCCGCGGTCCACCCCGGTGACGAACTGACCGTCGACATCACCTGGTCGCCGCGCGGCGAGCACTGGCGCTGCGCCGCCAAGGTGGCCACCGGCCGCGGCCCCGCCGCCTCGGTCCGCCTGCGCTACCGGCAGGAGGGAACACCGTGCTGA	MTGTVLAAARPVRGPAHDEDSGAWTAGFTVTITEDEPVFAGHYPDFPIFPGVCVMECVRRAAESAAPPVTGGLRLAAVESTRFLSAVHPGDELTVDITWSPRGEHWRCAAKVATGRGPAASVRLRYRQEGTPC	MHKHMSKLFIAFLAFLLSVPAAAEDQTLAELFAQQGIDGTIVISSLHNGKTFIHNDPRAKQRFSTASTFKILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNRDQTLESAFKVSCVWCYQALARQVGAEKYRNYLRKSVYGELREPFEETTFWLDGSLQISAIEQVNFLKKVHLRTLPFSASSYETLRQIMLIEQTPAFTLRAKTGWATRVKPQVGWYVGHVETPTDVWFFATNIEVRDEKDLPLRQKLTRKALQAKGIIE	50.76	gnl|BL_ORD_ID|696|hsp_num:0	758			429	522	cloxacillin; oxacillin; cefalotin
BGC0001297.1|WS9326_7 # 4599 # 5714 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.753	BGC0001297.1|WS9326_7 	4599	5714	-	Loose	500	27.335	OXA-53	29.79	3001810	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCCTTTCGGCGAGCGCGCCGGCGACCACGACCCGGCCGGTGATCACCGCCTGGTCCGCGGTGTCGCCGTACGGCATCGGCAAGGACAGCTTCGCGGCCGGCGTACTCGCCGGACAGGACACCTCCGCGCCGCTGGACTCCGGGCAGTGGGCGGCGCCCGACAGCCACGCCTGCCTGATCCCCGGCTTCGAACTGCGCGAGGTGCTCGGCAAGAAGGGCACCCGCTCCATGGACCGGGTGACCGGACTGGCCGTCACCGCCGTCCGCGACCTGCTGCGCGACTCCGGCGACCGGCGCACGGCCTCCGACGAGGAGACCGCCCTGGTGCTCGGCACCACCACCGGCAGCGCGCAGAGCATGATGGACTTCACCCGCGCCTCCCTCGAGGGCGACAAGCCGTTCTACGTCGACCCGTCGCTGATGCCGAACGCGGTGATGAACTGCGCCGCCGGCCAGTGCGCCATCTGGCACAACCTCAAGGGCCCGAACACCACCATCGCCGGCGGTCGCGTCGCCGGCCTGTCCGCGCTCAGCTACGCCGCCGGGCTGCTCGCCTCCGGCCGCGCCCGCACGGTGCTGTCCGGCGCGGCCGAGGAGTTCTCCAACGCCCGCGCCTGGCTGGACCACCACCGGCGCGGCGAGGACGGCGCGGACGCCCTGCTCGGCGAGGGCTGCGCCATGTTCATGCTGGAGTCGGCCGATCCGGCCGACGCGGCGGACCGCGCGCTGGCCGAGGTGCTGGCCGTGCAGTCCCGGGTCTACTTCGACGACGACCCCGGCGAGGCCCTCGCCGCCTGCGTGGACGGCGTGCTGCGGCGCGGGGGAGTGGACCGCGACGACGTGTGGGCGGTCTCCACCTCGGCGCCCGCCGGGAACGCGGGCACCCGCGAACGCGAGGTGCTCACCGCCCGCTTCGGCGCCCAGGTGCTCGACCGGGCCCCGTCCATGAGCGCCGTCGGGGACACCGCGGCCGCCTCCGCCGCCTTCCAGATCGGATCGCTGCTGGCCGCCGCCGAGCAGTCCGCGGTCCCGGCCGGCGCCGTCGCCCTCGTCTCCTCCGTGGACGACAACGGCGTCGTCGCCTGCGCCGCGCTGCGCCTGTCCGCGCGCTGA	MTLSASAPATTTRPVITAWSAVSPYGIGKDSFAAGVLAGQDTSAPLDSGQWAAPDSHACLIPGFELREVLGKKGTRSMDRVTGLAVTAVRDLLRDSGDRRTASDEETALVLGTTTGSAQSMMDFTRASLEGDKPFYVDPSLMPNAVMNCAAGQCAIWHNLKGPNTTIAGGRVAGLSALSYAAGLLASGRARTVLSGAAEEFSNARAWLDHHRRGEDGADALLGEGCAMFMLESADPADAADRALAEVLAVQSRVYFDDDPGEALAACVDGVLRRGGVDRDDVWAVSTSAPAGNAGTREREVLTARFGAQVLDRAPSMSAVGDTAAASAAFQIGSLLAAAEQSAVPAGAVALVSSVDDNGVVACAALRLSAR	MAIQIFAILFSTFVLATFAHAQDGTLERSDWGKFFSDFQAKGTIVVADERQADHAILVFDQARSMKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVKRSFAGHNKDQDLRSAMRNSTVWVYELFAKEIGDGKARRYLKQIGYGNADPSTSHGDYWIEGSLAISAQEQIAFLRKLYQNDLPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGSMGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIARAILLSIEALPPNPAVHSDAAR	134.91	gnl|BL_ORD_ID|1233|hsp_num:0	1341			477	618	cloxacillin; oxacillin; cefalotin
BGC0001297.1|WS9326_8 # 5815 # 6759 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.765	BGC0001297.1|WS9326_8 	5815	6759	-	Loose	500	31.5722	AIM-1	31.31	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	ATGATGACCGTCACCGGCGTCGGCGTCGCCCTGCCGGGCGCCGACTCCGCCACCGCCCTGGCCACCGCGAGCCGCCCCGGCGACAGCGTCGAACCGGCCGCCGTCCTGGGCAAGAAGGGCCTGCGCTACAAGGACCGCGCCACCCAGCTCGGACTGTGCGCCGCGCAGCGCGTGCTGACCGACGCCGGGCTGCTGGCCGACGGCGAGCTGACCGTCGACGGCACCCGCACCGCGGTGCTGGTCAGCTCCAACCTGGGCAACGTCGACACCGTCTGCCGCGTGGTCCAGACCATTGCCGACGAGGGTACCCACGGCGTCAGCCCCATGGACACCCCGAACGCCTCCAGCAACATCATCGCCTCCGAGATCGCCATCCGGTGGGGCCTCAAGGGCCCCAACCTGATGCTGTGCAACGGACCCGCCTCCGGGCTCGACGCGATCCGCTGGGGCACCGCACTGCTGCGCTCCGGCCGAGCCGACCACGTCGTCGTGGTGGGCGTCGAGCCGGACAACGAGATCGCGCGCCGCCTGGTCGGCGGCCCGCTGGCGGACGGCGCCGCCGCCGTGGTGCTGGAACGCGCCGAGGCCGCCGAGGCCCGCGGCGCCACCGTCCGGGCCGTCATCGGCGCCCACACCCGCGGCCTGGACGTGGCCGGCACCATCGCCGAACTGGCCGAGGTCGAGTCCGAGCCGGCCGCCTGGTACGCACCCGCGGCCGCCGCCCCGGCCCTGTCGCAGGGGCTGCCCGTGCACGACCTCGCCGCGGTGTGGGGCGAGTTGTCCGGGGCGCTCGGCGTCGTGCAGTGCGCGGCGGCGGTCGGCGCGCTCGACGCGGGCGCCGACGGCCCGATGTGGCTGGTGGCGGGGACCGACTCCGACGACGGCGTGGCCACGTTGGTGCTGCGCCCGCCGGTGCCGGCCGGCGCCCGCCCGGCCGCGGTCTGA	MMTVTGVGVALPGADSATALATASRPGDSVEPAAVLGKKGLRYKDRATQLGLCAAQRVLTDAGLLADGELTVDGTRTAVLVSSNLGNVDTVCRVVQTIADEGTHGVSPMDTPNASSNIIASEIAIRWGLKGPNLMLCNGPASGLDAIRWGTALLRSGRADHVVVVGVEPDNEIARRLVGGPLADGAAAVVLERAEAAEARGATVRAVIGAHTRGLDVAGTIAELAEVESEPAAWYAPAAAAPALSQGLPVHDLAAVWGELSGALGVVQCAAAVGALDAGADGPMWLVAGTDSDDGVATLVLRPPVPAGARPAAV	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	103.63	gnl|BL_ORD_ID|652|hsp_num:0	707			174	417	
BGC0001297.1|WS9326_9 # 6759 # 7898 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=7bp;gc_cont=0.740	BGC0001297.1|WS9326_9 	6759	7898	-	Loose	700	29.6462	vanS gene in vanA cluster	34.0	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAGGGTGCCCATCATCGGCGTCGGCGCCGTCGCGAGCGTCGGCCGGGACGCGGACGAGATCTTCGCCAACCTCTGCGCCGGCCGCGGCGGACTCGGTCCGATGCGCGGGTTCGACGGCGAACGCTACAACGGCAAGCAGCTGTTCGAGATCGACGACCGGCCGGAGCCGGGCGCCGACCGCCCGCTGCGCGCCACCGAGTTCCTGCTGGACGCGGTCGCCCAGGCCGCCGCGGACGCCGGCCTCGGCGACGACCTGTCCGGCGTGCCGGTGCTCGTCGGCACCGGCCTGCGCGAGCTGCGGTCGGCCGAACTGTGGTGGCGCGACGGAGCGCCGTTCGGCGCCGACCGGCTGCACTTCGGCACCGCGCTGCGGGAACGGTTCGGCACCGCCGACACCCTCACCGTCTCCAACGCCTGCTCCGCCTCCCTGTACACGCTGGCGCTCGGCGCCGACCTGCTGGCGCTGGGCGAGGCGGACACCGTCATCGTCGCGGGCGTCGACTCGATCACCGAGTCGATGCACGGCCTGGCCGACCGCGTCCAGCCCAACCCGCCGACCGCGCTGCGCACCCTCGACGTCAACCGCCGGGGCACCATCCTCGGCGACGGCGCGGCCGCCGTCGTGCTGCGCGGCGAGCAGGTGCGCTGGCCGGGCGGCCGGCTGTGGGGCAAGCTCCGCGGCGTCGGCATGACCTGCGACGCCAAGCACCCCACCGCCCCGGACCCGGTCCAGGTCGCCGAGGCGATGCGGCAGGCGCACCGGTTGGCCGGCACCCGGCCCGAGGACATCGACATGGTGCTGCTGCACGGCACCGGCACCCCGCTCAACGACCTGGTCGAGATCACCGCCTACGGCGAGGTGTTCGGCGAGGCCGCCGGCCGTCCGGTGCTCACCGGCATCAAGCCGATGACCGGCCACACCAGCGGTTCCGCGGGCCTGATGAGCCTCGTCACCACCCTGCAGGTGATGGCCACCGGCAAGGTGCCGCCCCTGGTCAACCTGGAGCAGCCCATCGAGGAGGCGGCCGGTCTGCGGCTGGTCCGCGGCCAGGAGGCCAAGCACGAGGTGGGGCTGGCGCAGGTGCACGGATTCGGGTTCGGCGGCGTCAACGCCGTAGCGATTGTCGAGGGATCATGA	MRVPIIGVGAVASVGRDADEIFANLCAGRGGLGPMRGFDGERYNGKQLFEIDDRPEPGADRPLRATEFLLDAVAQAAADAGLGDDLSGVPVLVGTGLRELRSAELWWRDGAPFGADRLHFGTALRERFGTADTLTVSNACSASLYTLALGADLLALGEADTVIVAGVDSITESMHGLADRVQPNPPTALRTLDVNRRGTILGDGAAAVVLRGEQVRWPGGRLWGKLRGVGMTCDAKHPTAPDPVQVAEAMRQAHRLAGTRPEDIDMVLLHGTGTPLNDLVEITAYGEVFGEAAGRPVLTGIKPMTGHTSGSAGLMSLVTTLQVMATGKVPPLVNLEQPIEEAAGLRLVRGQEAKHEVGLAQVHGFGFGGVNAVAIVEGS	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	98.70	gnl|BL_ORD_ID|1809|hsp_num:0	1907			423	564	vancomycin; teicoplanin
BGC0001297.1|WS9326_10 # 7895 # 9151 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.710	BGC0001297.1|WS9326_10 	7895	9151	-	Loose	750	173.711	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.88	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGTCAGTGAACGTTTCCGACGCGACGCGTGACGACGCGGCCACCCGGGTGGTGCTGACCGGGTTCGGCGTGTTCTCCAGCATCGGTGTGGGCGCCGATGAGTTCGCCGAAGGGCTGCGGGCCGGCCGCAGCGGCGCCAAGCCGATCACGCTGTTCGACACGGAGGGCTTCGCCCACGCCAACGGCTGCGAGATCACCGGCGCCGAACCCGAGCGCTGGATCCACAACCTGCCCACCGAGACCCTGGGCCGCGCCACGCAGTTCTCCGTGGCCGCCGCCCGCATGGCCGTCGAGGCCGCCGGCGCCGACCTGGACGACCTGCGCGCCCGGCGCGGCATGATCTCCATCGGCACCACCGACGGGGAGTCCTACGAACTCGACCACCTGGTCGGCACCGAGGTCGCCTCCGGACCGCAGGCCATGGACCCCACCGTGGCCCGCCGCGTCTACCCGAACCGCCTCTCCGTGGCCGCCGCCCAGGAGCTGGGCCTGTCCAACGTCGAGGCGGTCACCATCGCCACCGCCTGCTCGGCCGGCAACTACGCCATCGGCCAGGGCTTCGACGCCATCCGCAGCGGCGAGGTCGACTACGCCCTGTGCGGCGGCGCCGACGCCATGTGCCGCAAGACCTTCACCGGCTTCTACCGGCTCGGCACCATCGCCCCCGACGTGTGCCGCCCCTTCGACGTCGACCGCAAGGGCATCCTCACCGGCGAGGGCGCGGGCGTGCTGATGCTGGAGAGCCTCGCCTCCGCCCGGGCCCGCGGCGCCCGCATCTACGCCGAGGTGCTCGGCTACGGCATGAACTGCGACGCCTACCACCAGGTCGCCCCGAACCAGGACAGCGTCGCCCGCTGCATGGAGATCGCCCTGGAGAACGCCGGCGTCAAGGCGTCCGAGGTCGACCTGATCTCCGCCCACGGCACCGGCACCAAGGCCAACGACGTCACCGAGTCGCGGGCCATCCACGACGTGTACGGCGACACCGTGCCGCGCACCGTCTCCCTGAAGTCCATGCTCGGCCACACCATGGGCGCCGCCAGTGCGCTGGCCGCCATCGCCTGCGCCCTGTCGATCCACCACGGCTTCATCCCGCCGACCATCAACCACCGCGAGACCGACCCCGAGTGCGAGATCGACTGCGTGCCCAACCAGTCGGTCGAGGCGGACCTGAGGATCGTGCAGAACAACGGCCTCGCCTTCGGCGGCAACAACGCCATCGTGATCCTCGGCAAGTACCAGGAGGGTGTCCGATGA	MSVNVSDATRDDAATRVVLTGFGVFSSIGVGADEFAEGLRAGRSGAKPITLFDTEGFAHANGCEITGAEPERWIHNLPTETLGRATQFSVAAARMAVEAAGADLDDLRARRGMISIGTTDGESYELDHLVGTEVASGPQAMDPTVARRVYPNRLSVAAAQELGLSNVEAVTIATACSAGNYAIGQGFDAIRSGEVDYALCGGADAMCRKTFTGFYRLGTIAPDVCRPFDVDRKGILTGEGAGVLMLESLASARARGARIYAEVLGYGMNCDAYHQVAPNQDSVARCMEIALENAGVKASEVDLISAHGTGTKANDVTESRAIHDVYGDTVPRTVSLKSMLGHTMGAASALAAIACALSIHHGFIPPTINHRETDPECEIDCVPNQSVEADLRIVQNNGLAFGGNNAIVILGKYQEGVR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.48	gnl|BL_ORD_ID|1968|hsp_num:0	1943			369	1248	isoniazid
BGC0001297.1|WS9326_11 # 9267 # 9527 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.655	BGC0001297.1|WS9326_11 	9267	9527	-	Loose	450	23.483	rmtD	40.74	3002667	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGACCACCGCCATCGACACCACCGCCCAGGCCCGCATCAAGGAGATCGTCTGCGACGTCCTGGAGCTCGAAGAGGACGAGGTGACCGACAGCAGCCTCTTCAAGGAGGACCACGGCGCGGACTCGCTCCGCGCCATCGAGATCCTCGCGGGCCTCGAGAAGGAGTTCAAGGTCACCATCGAGCAGTCCGAGCTGGAGCGCATGGTCAACCTCGACGGCGTCTACGCCGTGGTGGGCGAGGCCGTCGCGGCCCAGAAGTAA	MTTAIDTTAQARIKEIVCDVLELEEDEVTDSSLFKEDHGADSLRAIEILAGLEKEFKVTIEQSELERMVNLDGVYAVVGEAVAAQK	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREYKRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYLAHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQRAGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	34.82	gnl|BL_ORD_ID|1702|hsp_num:0	1843			441	513	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0001297.1|WS9326_12 # 9670 # 11394 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.733	BGC0001297.1|WS9326_12 	9670	11394	-	Loose	600	28.8758	Streptomyces venezuelae rox	51.61	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGACAGCGACGCGCACGGCACCGCGCGCGGCACCGACTGGGATGCCGTGGTGGTCGGGGCCGGTCTCGGCGGTCTGACCGCCGCCGCGTATCTGGCCGCCGCGGGCAAGCGCGTCCTGGTACTGGAGCAGTTCTCGATCGTGGGCGGCAACAGCCATGTGTTCCGGCGACGCCGCGCCTACGAATTCGATGTGGGCGTCCACTACCTGGGCGACTGTGCACCCGGCGGAGTCATCCCGAGCATCCTGTCCGGTGTCGGACTCGGTGACCGGGTGGACTTCCTGGAGATGGACCAGGACGGCTTCGACCAGATCCGGGTGCCGGGCGTGTCCGTCGACATGCCCGCCGGCTGGGAGGCGTACCGGCGACGCCTCACGCAGGCCATGCCCGAGGAGGCCGCGGGCCTGAACGCGTTCGTCGACGTCTGCTCGGCGCTCGGCGAGGAGCAGCGCGCCGCGCTGTTCGAGGCCCACGCGTGGGCGCCGCAGGACATCGCCGCCCGCACCGCCACCATCCGGCAGTGGGGCCGGCGCACGCTGGACGACCTGTTCCGGCACTGCGGGCTGTCCTCCCGGGCCCGTACCGTGCTCGCCGCCCAGGCCCCCAACTACGGCCTCACCCCGAAGCAGGCCACGGTGGCGCGGCACACCAGCGTCACCGACCACTACCTGCGCGGCGCCTACTACCCGGCCGGCGGCGGACAGGTGCTCTCCGCGGGCCTGGTCGAGGTGATCGAGGCGCACGGCGGACAGGTCCGCACCCGCAGCCGGGTGGCCCGCATCCTCGTCGAGGACCGCAAGGTCGTCGGCGTCCACCTGGACGGCGGCGAGGTCATCACCGCCGACCTGGTGGTGTCCAACGCGGACTATCCGCGCACCGTGCTCGAACTGGTCGGCCCGGAACACTTCCAGAAGTCGGTCGTCACCCGCACCGCCGGGGCGAAGATGGGCATGCCGTGGCTGGTGCTCTACCTCGGCCTCGACACCGATCTGCGGGATCGGCCCAACGCCAACCTGTGGTGGTACGACACCGACGACATCGACGGCTACTTCGACCGGGTGAGCGGCGGCGAGACGGGCGACGTGCCCTTCCTGTTCTGCTCGTTCGCCTCGCTGAAGGACCCGCACAACCGGGAGCTGTGCCCGCCGGGACACGCCAACCTCCAGGTGATGACGCTCTGCCCGCCGGACTACGCGTGGTGGGGCGTCACGGACGGACCGGCCGACGGCGGCGACTACCGCCGCAACCCCACCTATCTGCGGCGCAAGCAGGAACTCACCGAGGCCACCCTGGACGCCGCCGAGAAGGCCCTCGGCCCGCTGCGGCCGCACCTCACCCACATCGAGGCGGCCACCCCGCTCACCCACGAGCGGTACACGCTGTCCACCGGCGGCACGCCCTTCGGCATGGCGGAGTGGGGCGGCACCGCCCGGCCCGGCACCGCCACCGCCGTCAGGGGACTGCACGTCGTCGGCGCCAGCACCCAGGCCGGCAACGGCATCGCCGGCGTCATGCTCGGCGGGATCGGCTGCGCCGCCGACATCCTCGGCGAGCCGCTGCTCGCCGCCGCCCGCGCCGGGACCGTGTACGGCGACCCGGACCTGCTGCCCGAACGGCCCGAGGGCTGGGACCCGAGGGAGGTGTGCCGCGGCGGTGCCCGGCGCACCACCACGCCCCGACCCTTCCGCCTCCCGTCGCCCGGCCTCGCCGGCGCACGCGAGTGA	MDSDAHGTARGTDWDAVVVGAGLGGLTAAAYLAAAGKRVLVLEQFSIVGGNSHVFRRRRAYEFDVGVHYLGDCAPGGVIPSILSGVGLGDRVDFLEMDQDGFDQIRVPGVSVDMPAGWEAYRRRLTQAMPEEAAGLNAFVDVCSALGEEQRAALFEAHAWAPQDIAARTATIRQWGRRTLDDLFRHCGLSSRARTVLAAQAPNYGLTPKQATVARHTSVTDHYLRGAYYPAGGGQVLSAGLVEVIEAHGGQVRTRSRVARILVEDRKVVGVHLDGGEVITADLVVSNADYPRTVLELVGPEHFQKSVVTRTAGAKMGMPWLVLYLGLDTDLRDRPNANLWWYDTDDIDGYFDRVSGGETGDVPFLFCSFASLKDPHNRELCPPGHANLQVMTLCPPDYAWWGVTDGPADGGDYRRNPTYLRRKQELTEATLDAAEKALGPLRPHLTHIEAATPLTHERYTLSTGGTPFGMAEWGGTARPGTATAVRGLHVVGASTQAGNGIAGVMLGGIGCAADILGEPLLAAARAGTVYGDPDLLPERPEGWDPREVCRGGARRTTTPRPFRLPSPGLAGARE	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	120.59	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	96	rifampin; rifaximin; rifapentine
BGC0001297.1|WS9326_13 # 11480 # 12205 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=4bp;gc_cont=0.737	BGC0001297.1|WS9326_13 	11480	12205	-	Loose	500	26.1794	MSI-OXA	29.82	3003719	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI-OXA family beta-lactamase	ATGGCTTCCCGCCGCCGGCCGCGCTGGTACTTCTCCCTGCGCAGCCCCTACTCCTGGTTCGCCTACCGCGACCTGATGAGCACCCACCCCGAGGTGCTCGACGCCATCGACTGGCTGCCGTTCTGGGAGCCGGACGAGGAGACCGCACGGCTGCTGGCCGACGAGGGCGTCACCCTCCCGATCGTCGCCATGAGCCGGGCGAAGAACTTCTACATCCTCCAGGACACCCGCCGGCTCGCCACCGAGCGCGGGCTGGACGTCAGCTGGCCGATCGACCGCGACCCCTGCTGGGAGGTGGCCCACCTGGCGTGGATCGCCGCCGACGACGAGGGCCGCGGCAAGGAGTTCGTCGCCGCCGCCTACCAGGCCCGCTGGCAGGACGGCAAGAACATCTCCGAGCCGGAGGTGATCGCCGGCATCGCCGAGGAACTCGGCCTGGACGCCCAGCGGCTGTCCACCGCGACCCAGGACCCCGACCTGCGCAAGCGGGGCGCGGCCCTGCTCGCCGAGTCCGCCCACGACGGCCTGTTCGGCGTGCCGTTCTTCATTCACGGCCGGGACAAGTTCTGGGGCGTGGACCGGGTCGCGCCGTTCGTCCGCGCCGTCCTCGGCACCGAAGCGGCCGAGTCCGCCCGGCAGTCGGCCGCCGACGCCCCGGACCCCGCCACCCACGCCGACCTGCTGGCGGCCGGCGGCGACCAGGGCCACGCCGGCGGCTGCGGCTGA	MASRRRPRWYFSLRSPYSWFAYRDLMSTHPEVLDAIDWLPFWEPDEETARLLADEGVTLPIVAMSRAKNFYILQDTRRLATERGLDVSWPIDRDPCWEVAHLAWIAADDEGRGKEFVAAAYQARWQDGKNISEPEVIAGIAEELGLDAQRLSTATQDPDLRKRGAALLAESAHDGLFGVPFFIHGRDKFWGVDRVAPFVRAVLGTEAAESARQSAADAPDPATHADLLAAGGDQGHAGGCG	MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL	88.60	gnl|BL_ORD_ID|2031|hsp_num:0	2234			102	438	
BGC0001297.1|WS9326_14 # 12234 # 13235 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.671	BGC0001297.1|WS9326_14 	12234	13235	-	Loose	500	27.335	CTX-M-151	21.15	3002008	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGGCCACCCTGACCGATGTCGACATCAAGAAGCTGCTGACCGAGCCGAGTTCGGTGACGATGCGCCCCTCCTACGAGGGCGGCAACATCAACACCGCGATCGGTTTCAAGTGCGACAACTACCTGCTCGAAGCGGCGGTGCTCGACCACTTCCGGGCCGTCGGCCTCGGCGCCACCGAGCTGTACCTGGTGCACGGCGTCAACTTCGACGTGGTCGGCGTCGACACGCGGCTGCACACCGTGCTCACCCTGGACGACGACGTGACCGTCGAGGTCACCCCCAAGACCAAGGACACCGACCGCGAGATGGTGTTCGCGGTGGCCGCGATCGTCGAGCGCGACGGCGCCCCCAAGAAGGCCGTCACCTCCAAGTTCCGCGTGCTGCTGCGCCGTGACACCAACATCGCCGACCCGGCGCCGCTCCCCGCGGAGCTGGAGCGCTTCGTCGTCGACCGGCTCGCCACCGCCGAGCCCGCCGAGCTGGCCTCCACCCCGGTGGACGACCTGCACGGCGCCTTCCACCGCGGTGAGGACGCCTCCACCGACCCGGTGCTCGCCGAGATCATCGGCGACGACAACGCCATCGGCTGGAAGTGGCGCATCCCGTACTACTACTGCCACTTCACCGAGCGCATGCAGATGTCGGGCTACCTGCGCCAGATGGAGGAGGCCAAGCACCTCTTCGTCGCCTCCCGCGGCATCAGCATCAAGCGGCTCCTCGACGAGCGCGGCTGGATCCCCGTGGTGACGCAGAACAAGCTGCACTTCACCGACGAGGCGATCATGGAGGAGGACCTGTACACGGTCTACACCGTGGAGTCCGTCTTCAAGGACATGCTCTACACCTCCCGCATGGACTTCTACGTGGTGCGGGACGGCAAGCTCGTCAAGACCGCCACCGGCGAGATCACCCACGGCTACTGCCACAAGGTGTCGCCGGACGCCGAGTGGCAGATGGCCGTCTTCGACGACGAGGTCCTGCGCGCGCTGCGCGGCGAGTGA	MATLTDVDIKKLLTEPSSVTMRPSYEGGNINTAIGFKCDNYLLEAAVLDHFRAVGLGATELYLVHGVNFDVVGVDTRLHTVLTLDDDVTVEVTPKTKDTDREMVFAVAAIVERDGAPKKAVTSKFRVLLRRDTNIADPAPLPAELERFVVDRLATAEPAELASTPVDDLHGAFHRGEDASTDPVLAEIIGDDNAIGWKWRIPYYYCHFTERMQMSGYLRQMEEAKHLFVASRGISIKRLLDERGWIPVVTQNKLHFTDEAIMEEDLYTVYTVESVFKDMLYTSRMDFYVVRDGKLVKTATGEITHGYCHKVSPDAEWQMAVFDDEVLRALRGE	MINKRLSIALALAAMIGTPVAMALESQKPGSDSANHIQHQMVQQLSALEKSANGRLGVAVIDTGSGAIAGWRMDEPFPMCSTSKVMAVAALLKQSEQTPELMSQPQPVASGDLVNYNPITERFVGKSMTFDELSAATLQYSDNAAMNLILAKLGGPQKVTAFARSIGDDKFRLDRNEPSLNTAIPGDLRDTSTPRAMALSLQKLALGDALGQVQREKLSHWLRGNTTGAASIRAGLPSGWSVGDKTGSGDYGTTNDIAVVWPTGRPPLVIVTYFTQPQQQAESQRPVLAKAAAIVASHYVLPKG	109.54	gnl|BL_ORD_ID|331|hsp_num:0	362			189	345	
BGC0001297.1|WS9326_16 # 14497 # 15699 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.778	BGC0001297.1|WS9326_16 	14497	15699	-	Loose	550	30.8018	NmcR	26.61	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	GTGACCGCCGGACACGTGGTGATCGTCGGCGCCTCGGTCGGCGGCAGCCGCCTCGCGGCGGGCCTGCGGGAGACCGGCCACACCGGCCGGATCACCCTGGTCGACCCCGACCCGGACGCCCCGTACGACCGGCCGCCGCTGTCCAAGCAGATCCTCGCCGGGGACTGGGACGAGCAGCGCGCCTCGCTCGGCGACCCCGCGCAGTGGAACGCCGAACGCCGGGTCGCCGCCGCGGCCGCCCTGGACACCGGCCACCGCCTGCTGCACCTCGACGACGGCACCCGCCTCGGCTACGACCGGCTGGTCCTGGCCTGCGGCGCCGCGCCGCGCACCCTGCCCGGCATGCCGCGCGACGGTGTGCACGTGCTGCGCACCCTCGCCGACTGCCGGCGGCTGCGCGCCGACCTCGACCGGATCGGCACCGGCCGGCTGGTGATCGTGGGCGGCGGCTTCGTCGGCGCCGAGGTGGCCTCCACCGCCCGCGCCCGCGGCACGGACGTGACCGTGGTGGAGGCGCTGCCCGCACCGCTGTCCGGGCTGCTCGGCGAGGAGGCGGCCGCCGAACTGGCCCTCCTGCACGCCGACAACGGCGTCCGCCTGCTCACCGGCACCGGCGTCACCGGCCTCGTCGGCGAGCCGTCCGTCACCGGCGTCGCCCTCACCGACGGCAGCGTGCTGCCCGCCGACGCCGTCGTCGTCGGCATCGGCGTGCGCCCCGGCACCGGCTGGCTGGCCGGCTCCGGCATCGCGCTGCACGACGACGGCGGCGTCCTGTGCGACGCGTACGGCGCCGCCGACGCCGAGCGCACCGTCTTCGCCGTGGGCGACGTCGCCCGCTGGCACGACCCGCTGCTCGGACGGCACGTCCGCGTCGAGCACTGGACCAACGCCGTGGAGCAGGCCGACGCCGTCGCCCGCACCCTCACCGGGCCCGAACCGGTGCCGTGCCGCGCCGAGTTCTTCGTCTGGTCCGACCAGTACGGCGGCAAGATCACCGTGCTCGGCCGGCCCGGCCCCGGCGACGAGGCCACCGTGGTGCGGGCCGACGCCGGGCGCCGCCGGTTCGCCGTCGCCTACCGGCGCGAGGACCGGCTGGCCGCCGTACTGACCGTCAACTGGCCCAAGGCGCTGCTCGCCGCCCGGCGGGCGCTGTCGGCACAGGGCGCCGCGGACGACGTCGTCGCCGCCTGGAAAGCCCTGTAG	MTAGHVVIVGASVGGSRLAAGLRETGHTGRITLVDPDPDAPYDRPPLSKQILAGDWDEQRASLGDPAQWNAERRVAAAAALDTGHRLLHLDDGTRLGYDRLVLACGAAPRTLPGMPRDGVHVLRTLADCRRLRADLDRIGTGRLVIVGGGFVGAEVASTARARGTDVTVVEALPAPLSGLLGEEAAAELALLHADNGVRLLTGTGVTGLVGEPSVTGVALTDGSVLPADAVVVGIGVRPGTGWLAGSGIALHDDGGVLCDAYGAADAERTVFAVGDVARWHDPLLGRHVRVEHWTNAVEQADAVARTLTGPEPVPCRAEFFVWSDQYGGKITVLGRPGPGDEATVVRADAGRRRFAVAYRREDRLAAVLTVNWPKALLAARRALSAQGAADDVVAAWKAL	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	135.59	gnl|BL_ORD_ID|1905|hsp_num:0	2072			333	639	cefoxitin; cefazolin; ampicillin
BGC0001297.1|WS9326_17 # 15696 # 17498 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.753	BGC0001297.1|WS9326_17 	15696	17498	-	Loose	1000	129.798	almE	29.12	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCACGTGAACACAACCCACACCACGGACGACACCATGGCTGACCCAACCCTCGCCGAACTCTTCCAGGCACAGGTGGCGCGCACCCCGCACGCCGTCGCCGTGCACAGCGGCGGGCAGGAGCTGGACTACGCCGGGCTCAACCGCCGGGCCAACCTGCTCGCGCACCGGCTGCTGGGCCGCGGCATCGGCCCGGAGGACGTGGTCGGGGTCCGGCTGCCCCGCTCCGCCGACCTGCTGGTGGCGCTGCTGGGCGTGCTCAAGACCGGTGCCGCCTATGTGCCGGTCGACGCCGACTGCCCGGCCGGCCGGCTGGCGTACATCGTCGAGGACACCGGCCTGGAGCTGATGCTCGTACCGGACGGCGAGGACGCCGACGGCACCGGTGAGGGTCCGCGGACGCTCTCGGTCCCCGCCGAGGTCGCCGCCGCCGAGGCGGCCGGCGGTCCCGCGCACGACCCCACCGACGCCGACCGCCCGGCCCCGCTGACCGCGCGGAACCTGGCGTACGTCATCTACACCTCCGGCTCCACCGGCCGGCCCAAGGGCGTGACGGTGCAGCACGACACCCTGCTGCGCTACCTGGACTTCGCCTGCGACGCCTACCCGGGCCTGGCGCGGAGCGCGCTGCTGCACTCCCCGGTCGCGTTCGACCTGACCGTCACCGCGCTGTACGGGCCGCTGCTGCGCGGCGGCCACGTGCGCGTCGGCTCGCTGGACCGGGAGCCCGAGCCCGGTACGCCGGCCGGGCGGCCCGCCTTCGTCAAGGCCACCCCCTCGCACCTGCCGCTGCTGACCGTGCTGCCCAGCAGCCTGTCGCCGACCGGTGAACTGGTCGTCGGCGGCGAGATGCTGATCGGCGACGTGGTCGAGCGGTGGCGCAAGACCCACCCCGGCGCGACCGTCGTCAACGAGTACGGGCCGACCGAGGCGACCGTCGGCTGCTGCGTCTTCGCCATCGGCCCCGACGACCCCGTCGAGCTCGGCGCCACGCCCATCGGCCGTCCGACCCCGGGCACCGAACTGCACGTGCTGGACGAGCGGTTGAACCCCGTTCCGGCCGGCACCGAGGGCGAGCTGTACATCGCGGGCGGCCAGGTCGCGCGCGGCTACCTGGGCCGGCCCGGGCTGACCGCGGAGCGGTTCGTGGCCGCGCCCGGCGGCGGACGCATGTACCGCACCGGCGACATCGCCCGGATGCGGCCCGACGGTCTCCTGGAGTACCTGGGCCGCACCGACGACCAGGTCAAGATCCGCGGCTACCGCATCGAACTCGGCGAGGTCACCTCGGTGCTGGCGGCCCAGGCCGGGGTGCGGCAGGCGGCCGTGATCGCCCGCGAGGACCGCTCCGGCGACCGCTACCTGGCCGGCTACGTGGTCCCCGAGGACGGCGCCGCCCCGGACCCGGCCGCGCTGCGCGAGGCCGTCGCCCGCCACCTGCCGCCCTACATGGTCCCGTCCGCCGTCGTCGTGGTCGGCGAACTGCCCCTGACCTCCAACGGCAAGCTGGACAAGGACGCCCTGCCCGAACCGCCGGCCGACGACGCGCCGACGGGCGCCGCCCCGGTGACCGAGGCGGAGACCCGGCTGTGCGCCCTGTTCGCCGAGGTCCTCGGCCTGCCCGTGGTCCACCTCGACGACGACTTCTTCGACCGGGGCGGGGACAGCCTGCGCGCCGCCAAGCTGGCCAACAAGGCCCGCAAGTCCGGCTGGACCTTCGGCCTGCGCGACGTGCTGGAGCTGCGCACCCCGCGCGCCCTGGCCCACGCCCCCGGCGCCCCGACCGAGGGAGCGGCGTCGTGA	MHVNTTHTTDDTMADPTLAELFQAQVARTPHAVAVHSGGQELDYAGLNRRANLLAHRLLGRGIGPEDVVGVRLPRSADLLVALLGVLKTGAAYVPVDADCPAGRLAYIVEDTGLELMLVPDGEDADGTGEGPRTLSVPAEVAAAEAAGGPAHDPTDADRPAPLTARNLAYVIYTSGSTGRPKGVTVQHDTLLRYLDFACDAYPGLARSALLHSPVAFDLTVTALYGPLLRGGHVRVGSLDREPEPGTPAGRPAFVKATPSHLPLLTVLPSSLSPTGELVVGGEMLIGDVVERWRKTHPGATVVNEYGPTEATVGCCVFAIGPDDPVELGATPIGRPTPGTELHVLDERLNPVPAGTEGELYIAGGQVARGYLGRPGLTAERFVAAPGGGRMYRTGDIARMRPDGLLEYLGRTDDQVKIRGYRIELGEVTSVLAAQAGVRQAAVIAREDRSGDRYLAGYVVPEDGAAPDPAALREAVARHLPPYMVPSAVVVVGELPLTSNGKLDKDALPEPPADDAPTGAAPVTEAETRLCALFAEVLGLPVVHLDDDFFDRGGDSLRAAKLANKARKSGWTFGLRDVLELRTPRALAHAPGAPTEGAAS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.91	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1650	colistin A; colistin B
BGC0001297.1|WS9326_18 # 17542 # 20478 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.771	BGC0001297.1|WS9326_18 	17542	20478	-	Loose	1000	132.109	almE	26.97	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTCTAGGGGACCAGTCGTGTCGATCACTCACCAGGACGCCGCCGCCGCGCGCACGCCCGAGCGGGCCGCCGCCCCGGCCGGCGCGGCCTGCCACGCACTGCGCGTACGCCTCACCGCCGGCGCCGCGGCGGACGGACCGGACGCGGTCGCCGCCCGGCTCACCGCCCTGACCGCCGGCACCGGCCCGTCGGCGGGCTTCCCCGCGCGGCTGTGGACCGAGCGGGTGCCGTGCGGCGCCGACGCGCCCGCCGCCCGGCGGTGGCGGGACCGCGAACTCGGCCGCCCGCTGCCCGTCCACCGGGACGCCCCGGTCCGGGCGGTGCTGCTGCAGTACGCCGACGGCGCCACCGACCTGGTCGTGGTCGCCGACCGCGCCGCCCTGGACACGACGGCCCTGCACGCGTTCACCGCCCGCCTGCTCGGCGCCGAGCAGGACACCGCCCTCACGGCCCGCACCGCCGCCACGTCGCCGCCCGCCGAGCCCGGCCCGGGCGGCCCCGTGGAGCAGCCCGACTGGGGGCTCGGCCGGCCGCACGGCCCGGACACCCCGGTGACCCGTGTGCTGCCGCTGCCCGCCGGGCACCCCGAGACGGACGCCGAGAGCTGGGCCACCGCCCTCGGTGTCGTCCTCGCCCGCTACGAGGGCGTCACCCGGCCCGCACTCGCGCTGCTCGCCCCCGGCACCGGCGCCCCGGGCCGCCCGGTCGTCCCGGCACCGGTCGCGGCGGACGGCGGGAGCACCCTCGGCACCGTCGACAAGGAGCTGCGCGCCGCCCTGGCCGCCGGCCCGGACGGGACCGCCACGACGGCCGCGGTGGGCCTGGTCCTCGCCGACCGCGACCTATCCGCCGGCCTGCCCGGCGCGGACCACGCCGAGTACCGGCCGTTCCAGCAGCCGCCGTTCCCGGTGACCGTCACCGTGACCCGGGACGCGACCGGCGGACGGGCCCTGCGCTGCGACCACTCCGCGCGCACCCTGTCCGACGCCGTCGCCGACCAGTTGCTGCGGCACGTGAGCCAGGTGCACCGCACGCTCGCCGAGGCCCCGGACACCCTCGTCGCCGACGCCCGCCCGTGGGACGAGGAGGAGGCCGCACGCCTGGCCGCGCACCGCCGGTCCGCGCCGCTGCCGCCGTTCACGCCGCGGCGCATCGACACCGCGGTCGCCGAGATCGCCGCCGCCCGGCCGGACGCCGTCGCCGTCCGCTGCGAGGACACCCGGCTGACGTACGGCGAACTCGACCGCCGCGCCGACCGGCTGGCGCACGCGCTGCGCGCGCTGGGCGTCGGGGACCGCGACCGGGTCGGCGTGTGCCTGGAACGCTCGGCCGAGATGATCGTCGTGCTGCTCGCGGTCCTCAAGGCGGGCGCCACCTACGTACCGATGGACCCCGCCTACCCGGAGGACCGGCTCGCCTACACGACCTCCGACGCCGGACTCACCACGGTCCTCACCGACCGCGCCGACTTCCCCGGCGGCACCGACACCCGGGTCCTGACCCCGGCCGCACTCGAGGACCTGGCACCCGAACGGTGCGACGGGCCGCCGCCGTCGGCGGCCGGCGCCGACGACCCGGCGTACGTCATCTACACCTCCGGCTCCACCGGCCGCCCCAAGGGCTGCGTCGTCCCGCACGTCAACGTCCTCAGCCTGATGGCCGCCACCACCGGCGACTTCGGGCTCGGCGCGGACGACACCTGGACGCTCTTCCACTCCAGCGCGTTCGACTTCTCGGTGTGGGAGATCTGGGGCTGCCTGCTCACCGGCGGCCGGCTCGTGGTCGTCCCCTACTGGGTGTCGCGCTCGCCGGAGGACTTCCACCGGCTGCTGCGCGAGGAGCGGGTGACGGTGCTCAGCCAGACCCCGTCGGCCTTCGCCCACCTGGTGGAGGTGGAGCGGGACGGCGCCGACCCCGCGCCGGTCCGGCTGGTCGTCTTCGGCGGCGAGGGACTCGACCCGCGGATGCTGCTGCCCTGGTTCGACCGCCACCCGGAGACCGCGTGCCGGGTGGTCAACATGTACGGCATCACCGAGACCACGGTGCACGTGACCGCGCAGACCGTCACCCGCGCCGAGGCGCTCACCGCCTCCAAGTCGGTCGGGCACGCGCTGCCCGGCTGGTGGGTGCGGGTCGCCGACCCGGACGGCCGGCCGCTGCCCGCCGGTGTCGCCGGTGAGATCTACGTCGGCGGCGCCGGCGTCGCCGCCCACTACCTGAACAAGCCCGAACTCACCGAGCAGCGCTTCCTCACCGACGTGCGCACCGGCGAGCGGCTGTACCGCAGCGGCGACAAGGGCCGGCTGCTGCCCGACGGACGGCTGGAGCACCTGGGCCGGCTGGACAGCCAGGTCAAGCTGCGCGGCTTCCGCATCGAACTCGACGAGATCCGCTCGGTGCTGCTGGACGACCCGCAGGTCACGGCGGCGGCCGTGGTCCTCAACCGGACCGACCCGGACGACGCGGCGACCGCACAGCTCGACGCGTACGTGGTGATGGACGGCGACGACACCGCCTCCGTGCGGCAGCGCGCCACCCGCTTCCTGCCCGAGTACATGGTCCCGTCGACGGTCACCGCACTGGAGCGGATGCCGCTGACCACCAACGGCAAGCTGGACACCCGCCGGCTGCCCCGGCCCGCCGCGGCCCCCGCGCCCGCCGCGCCTGCCGCACCCGCCGCCACGCCCGCCGCCGCGCAGGCCGAGTCCGCCGCGGCGCAGGCCGACACGTTCGAGCAGGTGCTGCTGGAGGTCTGGCGGGAGGTGCTCGGCGTGCCGGTCGGCCCGGACGACAACTTCTTCGACCTGGGCGGCAACTCACTGCTCGCCATGCGGGTGGGCGCCGCGCTGCGCCGACGCGGCGGGCACACGGTGGCCATGCGCGACCTGTACCTGCGTCCGACGATCCGGCAGCTCGCCGCGGACCGCGCCGGATGA	MSRGPVVSITHQDAAAARTPERAAAPAGAACHALRVRLTAGAAADGPDAVAARLTALTAGTGPSAGFPARLWTERVPCGADAPAARRWRDRELGRPLPVHRDAPVRAVLLQYADGATDLVVVADRAALDTTALHAFTARLLGAEQDTALTARTAATSPPAEPGPGGPVEQPDWGLGRPHGPDTPVTRVLPLPAGHPETDAESWATALGVVLARYEGVTRPALALLAPGTGAPGRPVVPAPVAADGGSTLGTVDKELRAALAAGPDGTATTAAVGLVLADRDLSAGLPGADHAEYRPFQQPPFPVTVTVTRDATGGRALRCDHSARTLSDAVADQLLRHVSQVHRTLAEAPDTLVADARPWDEEEAARLAAHRRSAPLPPFTPRRIDTAVAEIAAARPDAVAVRCEDTRLTYGELDRRADRLAHALRALGVGDRDRVGVCLERSAEMIVVLLAVLKAGATYVPMDPAYPEDRLAYTTSDAGLTTVLTDRADFPGGTDTRVLTPAALEDLAPERCDGPPPSAAGADDPAYVIYTSGSTGRPKGCVVPHVNVLSLMAATTGDFGLGADDTWTLFHSSAFDFSVWEIWGCLLTGGRLVVVPYWVSRSPEDFHRLLREERVTVLSQTPSAFAHLVEVERDGADPAPVRLVVFGGEGLDPRMLLPWFDRHPETACRVVNMYGITETTVHVTAQTVTRAEALTASKSVGHALPGWWVRVADPDGRPLPAGVAGEIYVGGAGVAAHYLNKPELTEQRFLTDVRTGERLYRSGDKGRLLPDGRLEHLGRLDSQVKLRGFRIELDEIRSVLLDDPQVTAAAVVLNRTDPDDAATAQLDAYVVMDGDDTASVRQRATRFLPEYMVPSTVTALERMPLTTNGKLDTRRLPRPAAAPAPAAPAAPAATPAAAQAESAAAQADTFEQVLLEVWREVLGVPVGPDDNFFDLGGNSLLAMRVGAALRRRGGHTVAMRDLYLRPTIRQLAADRAG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	175.90	gnl|BL_ORD_ID|4935|hsp_num:0	5928			102	1647	colistin A; colistin B
BGC0001297.1|WS9326_19 # 20503 # 21327 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.722	BGC0001297.1|WS9326_19 	20503	21327	-	Loose	450	47.7506	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	25.69	3004045	protein variant model	F203L	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	GTGCGCCTGCAAGGAAAGACCGTCGTCGTGACGGGAGCCGCGCGCGGGGTCGGCCGTGCCTGCGCGCTGGCGTTCAGCCGGGAGGGAGCCGATCTCGCCCTGCTCGACGTGTGCGGTGACGTGGACGGCGTGCCCTACCCGCTCGGTACCGTCAGCCAGCTGGACCACACCGCGCGGCTCTGCCGTGAGCAGGGCGCCGCCGTGCTCACGGCCACCGCCGACGTCCGCGACGGCGCCGCCCTGCGCGCGGCGGTCGACGCCACGCTCGACCGGTTCGGCGCCGTCGACGTCCTCGTCAACAACGCGGGCATCGTGGCGCCGTCGGGCCGGACCACGCACGAGATCACCGAGGACGAGTGGCAGGTGATGCTCGACATCAACCTGTCCGGCGCCTGGCGCATGATCTCGCTGGTCGGCCCGCACATGGTGGCCCGCCGCTCCGGCAGCATCGTCAACGTCGCCTCCACCGCCGGACTGGTGGGCTACCGGCACTTCGCCGGCTACACCGCCTCCAAGCACGGCCTGATCGGACTGACCCGGGCGACGGCCCTGGACTACGCCCCGCTCAAGGTCCGCGTCAACGCCCTGTGCCCGGGCTCCATCCGGGACGACAGCGCGGTCGAGGGCCGGATGCTCACCGAGATCGCCAGGTCGCTGGAGCTGCCGGTCGGCGAGCACGAGCAGACCTTCGTCCAGTCGCAGCCGATGAACGCGCTGATCGAACCGGAGGACGTGGCGGGTGCCGCGCTCTGGCTGGCCTCCGACGAGTCCCGGCAGGTGACGGGCTCCGTGCTGACCGTCGACGGCGGCTTCACCATCCGCTGA	MRLQGKTVVVTGAARGVGRACALAFSREGADLALLDVCGDVDGVPYPLGTVSQLDHTARLCREQGAAVLTATADVRDGAALRAAVDATLDRFGAVDVLVNNAGIVAPSGRTTHEITEDEWQVMLDINLSGAWRMISLVGPHMVARRSGSIVNVASTAGLVGYRHFAGYTASKHGLIGLTRATALDYAPLKVRVNALCPGSIRDDSAVEGRMLTEIARSLELPVGEHEQTFVQSQPMNALIEPEDVAGAALWLASDESRQVTGSVLTVDGGFTIR	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	104.58	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	759	triclosan
BGC0001297.1|WS9326_20 # 21378 # 22079 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.732	BGC0001297.1|WS9326_20 	21378	22079	-	Loose	1000	25.409	MCR-8.2	23.85	3007229	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGCAAAGACGGTCGTGCTCTGCGTGCCGTTCGCCGGGGCCGGCGCCTCGGTCTTCCGCCCCTGGGTGCCGCTCGCCCAGGACCGGTTCGACCTCGCCGCCGTCCAGCTGCCCGGCCGTGAGCAGCGCTTCGCGGAGGAGCCCTACCAGGACGCGGTCGCCGCCGCCGACGGGCTGCTGCCCGAGGTGCTGGAGCGGGTCAAGGGCGCCGGCCCGGTCGTCCTGTTCGGCCACAGCCTCGGCGCGGTCCTGTCGTACGAGATCGCCCACCGGCTGGCCGCGACCGACGGCGTCGAGCTGGCCGCCCTGGTGGTCAGCGGCTCGCCCGGGCCGTGGACCCGCCGCGAGAACGGCGCCAGCGGACTCGACGACGACCAGTTCCTGGAGCGCGTCAAGGAGTTCGCCGGCTACCGCCACGACGCCCTGGAGGACCCGGAGATGCGGGAGCTGCTGCTGCCCACGCTCCGCGCCGACGTGGAGATGCACGAGAGCTACGTCCCGTCCTCCGACCAGCCGCTGCCCGCGCCGATCGTCTCCGTGCGCGGCACCACCGACACCCTGGTGACCACCGAGCAGGCCATGGAGTGGTCCAAGGCCACCAGCAGGGACTTCCGGTTCGTCGAGGTCGAGGGCGGCCACATGTACCTGGTCGACAACCCCGAGGGCCTGATCGACGTGCTCGCGGACGTCCGCCCGGCCTGA	MAKTVVLCVPFAGAGASVFRPWVPLAQDRFDLAAVQLPGREQRFAEEPYQDAVAAADGLLPEVLERVKGAGPVVLFGHSLGAVLSYEIAHRLAATDGVELAALVVSGSPGPWTRRENGASGLDDDQFLERVKEFAGYRHDALEDPEMRELLLPTLRADVEMHESYVPSSDQPLPAPIVSVRGTTDTLVTTEQAMEWSKATSRDFRFVEVEGGHMYLVDNPEGLIDVLADVRPA	MFKYLLSFKLNPVQRTWAAAFFFTTIGNIALWQTLWINVDVHNIHNLLFFVSLPIFLFCFLSILLTPVMVIPYLCRPLLVVLILISACCSYFMMKYNILIDRSMVQNFFETNQAELTSYLSVPFLSTLFLLGIVPAIILALPSTDNKRGAFRIELWWLAHICIAVVLLAMVTMVFYKDYASLIRNNMQIKDQALPFNFVRNTNGYLKRKYQASSTILQSVGEDAVRPIYSNSPPKLVVVVVGETARAQNFQLNGYSRVTNPYLSRRHDVISFKNVSSCGTATAISLPCMFSRMSRNEYNEVRAASEENLLDILKRTGVEVLWRNNNNGGCKGICKRVPTDDMPAMKVIGECVNKDGTCFDEVLLYQLSSRINAMQGDALIVLHQMGSHGPTYFERYPSTSKVFSPTCDSNLIEKCSNKELVNTYDNTLVYTDRMLSKTIELLQRYSGMRDVAMIYLSDHGESLGESGIYLHGTPYIIAPKEQTHIPMFMWFSSSFAQHSKLNLECLTGNADKQYSHDNFYHSILGLFNVKTSVYKPELDMFTLCRQSDHTPLSSAVVREKTDGNG	41.24	gnl|BL_ORD_ID|4849|hsp_num:0	5834			843	1170	colistin A; colistin B
BGC0001297.1|WS9326_21 # 22137 # 27815 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.740	BGC0001297.1|WS9326_21 	22137	27815	-	Loose	1000	151.754	almE	28.54	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCAGCAACGACCTCTTCGAGGACATCCTTCCCCTGGCACCGCTGCAGGAGGGGATGCTCTTCCACGCGACCTACGACGAGGACGCCCTCGACGTCTACACGGTGCGGCTGGCCATCGACTTCGAGGGCCCCTTCGACCTGGACGTGTTCCGCGACGCGGTGCGCGCGCTGCTGATCCGCCGCAGCAACCTGCGGGCCGGATTCCTCTCGGAGAACCTGAGCCGGCCGGTCAGCGTCGTGCCGCGCGCCTTCGACACGCCCGTCGTCGTGCACGACCTGTCCGCGCTCGGCGGCCCCGAGCGGGCCGAGCGCCTCGCCGAACTGGAGGCGGCCGAGCGGGCCGTGCGCTTCGACCTGACCGCGCCGCCGCTGCTGCGGTTCACCGTGGTGCGGCTGGCGGAGAACGGCTGGCGGCTGATGTTCGCCTGCCACCACATCCTGCTCGACGGCTGGTCCATGCCGATCGTGCTCGGCGAGCTGTTCGCGCTGTACGGCGCGCGCGGCGACGCCTCCGTGCTGCCGCCCGCCGCGCCCTTCAAGCTGTACCTGGCCTGGCTGCGCAAGCAGGACAAGGAGCAGGGCCTGACGGCGTGGCGGTCCGCGCTCGACGGCCTGCGCGGCGCCACCCTGGTCGCCCCGGACGCCGACGACACCGTCGACACGCTGCCGGGCCGGATCGTCGCCGACCTGCCGGCCGGACCGAGCGCCCGCCTGACCGCGCTCGCCCGCCGCCTCGGCATCACCGTCAACACCGCCGTGCAGGCCGCCTGGGGCCTGCTGCTGGCCCGGCTCACCGGCACCGAGGACGTCGTCTTCGGCGCGACGGTCTCCGGACGCCCGCCCGAGCTGGACGGCGTCGAGACCATGGTGGGCCTCTTCATCAACACCGTGCCGGTGCGGGTCCGGCTCGCGCCCGGCGAGTCCCTGCGCGAGCTGCTGCTGCGGGTCCAGGACGAGCAGTCCGCGCTGCTGGACCACCACTACATCGGCCTGACCGAGGTGCAGCGCGCGGCGGGCCACGGCCGGCTCTTCGACAGCCTCGTCGCCTTCGAGAGCTACCCGGTGGACGCGGACTCCCTCCAGTCGTCCATCGGCGACCTCACCGTGACCGGTGTCTCCGGCGACGACGCCACCCACTACCCGCTGACGCTGATCGTCGTGCCCGGCGAGCGCGTTCAGCTGCGCCTGGGCCACCAGGGCGGCGTGTTCACGCCGGAGGTGGCCGGCGCCCTGCTGACCGAGCTGGAGCGGCTGCTGACGGCCGTCGCCGACGACGACACGCGGCCGGTGACCGAGGCGCTGGCGTCGGTCACCGTGCCCGGCGGCTGGCCGGCGTCGGCCGCGCGGGCCGACGGCGGCGGCACGGGCGGCACCTCGGTGTCGGACCTGACCGTCGTCTCCGGCGAGGGACGGGCCCCGAGGACCCCGCACGAGGAGGTGCTCTGCGGACTGTTCGCCGAGGCCCTCGGCGTGCCGTCGGTCTCCATCGACGACAACTTCTTCGACCTGGGCGGCCATTCGCTGCTCGCCACCCGGCTGGTCAGCCGCGTCCGCAGCGTCTTCGACATCGAACTCCCCGTCCGCGCCCTGTTCGACGCGCAGACGGTGGCGGCGCTCGCCGAGCGCGTGGTCGGCTCGTCGGTCGGCGGACGGCCGCCGGTGCGCGCGGCGGCGGAGCGCCCGGAGCGGGTGCCGCTGTCGTTCGCGCAGCGCCGCCTGTGGTTCCTCAACCGCATGGAAGGCCCGAGCGGCACCTACAACATTCCGCTGGCCGTGCGGCTGTCGGGCACGCTGGACGTGGCCGCGCTGCGGTCGGCGCTGGTGGACGTCGTGGGCCGGCACGAGTCGCTGCGCACGGTGTTCCCCGACGCGGACGGTCAGCCCTGGCAGCAGGTGGTGCCCACGGCCGACGTCGACCTGCCGCTCGAGGTCGTCGAGGTGACCGAGGAGGACCTGGAGGCCGCGCTGGCCTCGGCGGCCTCGGCCGGGTTCGACCTGGCGGCGGACCTGCCGGTGCGGGCCTCGCTGTTCCGGGTCTCCGCGACCGAGCACGTGCTGTGCGTCGTCGTGCACCACATCGCGGGCGACGGCTGGTCGCAGGCGCCGCTGGCGCGCGATCTGGGACTGGCCTACCGGGCGCGGCTGACGGGTACGGCGCCGGAGTGGGAGCCGCTGCCGGTGCAGTACGCGGACTACGCGCTGTGGCAGCGGGACGTGCTGGGCGGCGAGGACGACGCCGACTCGCCGATCGCCGCGCAGCTCGCGTACTGGCGCGACGCGCTGGACGGGATCCCGGACGAGCTGAGTCTTCCGGTGGACCGGGCGCGGCCCGCGGTGGCGTCGTACCGCGGCGGTGTGGTGTCGGTCGAGCTGGGTGCCCGGCTGCACCGGGACCTGGTGGGCCTCGCCCGCTCCACCCGGTCGTCGCTGTTCATGGTGTTGCAGGCCGGTGTGGCCGGTCTGCTGTCCCGGCTGGGCGCGGGAACGGACGTGCCGCTGGGCACGGCGATCGCGGGCCGTACCGACGCCGCCCTCGACGACCTGGTCGGGTTCTTCGTGAACACGCTGGTGCTGCGCACCGACGTCTCCGGCGACCCCGGGCTCAAGGAACTCGTGGAGCGGGTCCGCGTGACGGACCTGGCCGCCTTCGCCCACCAGGACCTGCCGTTCGAGCAGTTGGTGCACGCAGTGCAGCCGGCCCGTTCGCTGGCCCGGCACCCGCTGTTCCAGGTGATGATCGTCCTGCAGAACAACGCGGTCGCCTCGCTGGACCTGCCCGGCCTGACCGCCCGCCCGATCGACGGGGACACCGCCGCGGCCAAGTTCGACCTCGGCTTCAACTTCGTCGAACGCACCGACCTCGACGGCGCACCCGCCGGCATCGACGTCTCCATCGAGTACAGCGCCGACCTGTTCGACGCAGACACCGTGCGGCTCATCGGCGAACGGCTCGCCCGGCTGCTCACCACCGGCGTCGCCGAGCCGGCGACCCCGCTCACCCGCATCGACATCCTCGCCCCCGACGAGCACGACCGGCTGGTCACCGGCTTCAACGACACCGCCCGCACCCTGGAACTGCCGCCCGTGACGGAGTCCGGCTTCGCGCCGGAGACCATCGCCGGACTGTTCGCCGCCCGCGCGGCGAGCACCCCGGACCGGCCGGCGGTCATCGGCGAGGACGCCGAACTCGGCTACGCCGAACTCGACGACCGTTCCTCCCGGCTGGCCGCGCTGCTCGCCGCCCGGGGCGTGCGCCGCGGCGACGTGGTCGCGGTGGCCGTGCCCCGCTCGGCCGCCCTGACCGTGGCCCTGCTCGCCGCGCTCAAGGCGGGCGCCGCCTACCTGCCGGTGGAGACCGACTACCCGGCCGAGCGCATCGCCTACGTCCTCGGCGACGCCCGCCCGGCCGTCCTGGTCACCACCTCGCAGGCGCTCGCCGCCCTGCCCGAGGAGATCAAGGGCACCGTCCGCTCCCTCGTCGTGCTGGACGACCTCGGCACCGACTGGGAGCTGGCCGCCGTGGCCGCCGAGGAGATCCGGGCCCTGCCCGGCCCGCTGCCTCAGTCACCCGCGTACGTCATCTACACCTCCGGTTCCACCGGCCGTCCCAAGGGCGTCGTCGTGCCCCACCGCGGCATCGTGAACCGGCTGCTGTGGATGCAGGACACCTACCGCATCGGCGCCGACGACCGGGTGCTGCAGAAGACACCGTCCGGATTCGACGTCTCCGTCTGGGAGTTCTTCTGGCCGCTGGTGGCCGGCTCCACGCAGGTCGCCGCCCGGCCCGGCGGCCACCGCGACCCCGCCTACCTGGCCCGGCTCGTCCAGGAGTCGGGCATCACCACCGTCCACTTCGTGCCGTCCATGCTGGAGGTGTTCCTCGCCGAGCCGGAGGCCGCCCGCTGCACCGGGCTGCGCCGCGTGCTGTGCAGCGGCGAGGCCCTGCCCGCCGGACTGCGCGACCGGTTCCGGGCCGCGCTCGGCGGCGTGGAACTGCACAACCTGTACGGCCCGACCGAGGCGTCCGTCGACGTCACCGCCTGGGACTGCGCCACCGCCGCGGACACCGCGTCCGTGCCGATCGGCCGGCCCGTCTGGAACACCAGGACCCACGTACTGGACGCCGCCCTCAACCCGGCCCCGACCGGCAGCAGCGGCGAACTGTACCTGGGCGGCGTGCAGTTGGCGCACGGCTACCTGAACCGCCCGGACCTGACGGCGGAACGCTTCGTGGCCGACCCGTACGGCCCGCCCGGCTCCCGGCTCTACCGCACCGGCGACCTGGCCCGCGTCACCCGCGACGGAGTGATCGAGTTCCTCGGCCGCACCGACGACCAGGTGAAGATCCGCGGACAGCGCATCGAGCTGGGCGAGATCGAGCACGCGCTCACCCGGCACCCGCGCGTCGGCAGCGCCGTCGTCACCGCGCACCGGGACGAGTCGGGCGACACCCGCCTCGCCGCGTACGTCACCGTCACCGACCCGGCCGCCCCCGTGGAGCCGGAGGAGCTGCGCGACCTCCTCGCCGCGCTGCTGCCCGACCACATGGTGCCCGTGCACTACGCGGTCATCGACGCCGTACCGGTCACCCCGAACGGCAAGGTCGACAAGAAGGCGCTCCCCGCGCCCCGCCTGCTCGACCGCCGCCCGGGCCGCGCCCCGCGCGACGAGAACGAGACGGCGCTGTGCGAGATCTTCGCCGAACTGCTCGGCCACGACACCGTGCACATCGACGACAACTTCTTCGAACTCGGCGGCCACTCGCTGCTCGCCACCAAGCTCATCAGCCGCGTCCGCGACCGGCTCGGGGCCGAGCTGTCCGTGGTGTCGATCTTCGAGGCGCCGACGGTGGCGACACTCGCCGGCCGCCTCGGCCGGGACGCCACGACCGGACCGACGAGCCCGCTGCTGACCCTGCGTCCCGGCGGCACGGACACCCCGCTGTTCTGCGTCCACCCGCTCGGCGGCCTCAGCTGGCCGTACGCCTCTCTCGCCGAGCACCTGCCGACGGAGGTCGGCCTGCACGGCCTGCAGGCCGTCGGACTCGACGGCGACGAGCCGCTGCCGGAGACGCTTCAGGAGATGGCGGACGACTACGTGGCCCGGGTCCGCTCGGTCCAGCCGGAAGGCCCCTACCGGCTGCTCGGCTGGTCGCTCGGCGGCCGGATCGCGCACGCCATGGCCGAACGGCTGGAGGCCGCGGGCCAGGAGGTCGAGCTGCTCGCCCTGCTGGACGCCTACCCGAGCACCACCGTCGACACCGACGCGCGTTTCTCCGAACGCGAGTTCCTCGACGGCATCCTCTCCGCCGCCGGACTCGACGCGTCCGCGCTGGACGGCCCCGTCGACATCGACACGGTCATGGCGGCGGTGCGCTCCACCGGCGACGACCTGGCCGGCCTCACCGCCGACCAACTGCGCCGCCTCCAGCGGGTCATGGCGAACAGCTTCCGTCTCGACGGAGCCGCGCGCACCGGCCGCTGCCGGGCGGGCGCGGTGATGTTCGCCGCGACCGTCGACCCGGCCGGCGACCCCGACCACTGGCACGGCCACGTCGACGGCGGCCTGGAGATCCACACCGTCGCCGTCGGCCACAACGACCTGATGCGGCCGGAACCGCTCGCCGAGATCGGGGCGGTGCTGGCGAAGAAGCTGGCCCGCACCTCCGGCGCCTGA	MTSNDLFEDILPLAPLQEGMLFHATYDEDALDVYTVRLAIDFEGPFDLDVFRDAVRALLIRRSNLRAGFLSENLSRPVSVVPRAFDTPVVVHDLSALGGPERAERLAELEAAERAVRFDLTAPPLLRFTVVRLAENGWRLMFACHHILLDGWSMPIVLGELFALYGARGDASVLPPAAPFKLYLAWLRKQDKEQGLTAWRSALDGLRGATLVAPDADDTVDTLPGRIVADLPAGPSARLTALARRLGITVNTAVQAAWGLLLARLTGTEDVVFGATVSGRPPELDGVETMVGLFINTVPVRVRLAPGESLRELLLRVQDEQSALLDHHYIGLTEVQRAAGHGRLFDSLVAFESYPVDADSLQSSIGDLTVTGVSGDDATHYPLTLIVVPGERVQLRLGHQGGVFTPEVAGALLTELERLLTAVADDDTRPVTEALASVTVPGGWPASAARADGGGTGGTSVSDLTVVSGEGRAPRTPHEEVLCGLFAEALGVPSVSIDDNFFDLGGHSLLATRLVSRVRSVFDIELPVRALFDAQTVAALAERVVGSSVGGRPPVRAAAERPERVPLSFAQRRLWFLNRMEGPSGTYNIPLAVRLSGTLDVAALRSALVDVVGRHESLRTVFPDADGQPWQQVVPTADVDLPLEVVEVTEEDLEAALASAASAGFDLAADLPVRASLFRVSATEHVLCVVVHHIAGDGWSQAPLARDLGLAYRARLTGTAPEWEPLPVQYADYALWQRDVLGGEDDADSPIAAQLAYWRDALDGIPDELSLPVDRARPAVASYRGGVVSVELGARLHRDLVGLARSTRSSLFMVLQAGVAGLLSRLGAGTDVPLGTAIAGRTDAALDDLVGFFVNTLVLRTDVSGDPGLKELVERVRVTDLAAFAHQDLPFEQLVHAVQPARSLARHPLFQVMIVLQNNAVASLDLPGLTARPIDGDTAAAKFDLGFNFVERTDLDGAPAGIDVSIEYSADLFDADTVRLIGERLARLLTTGVAEPATPLTRIDILAPDEHDRLVTGFNDTARTLELPPVTESGFAPETIAGLFAARAASTPDRPAVIGEDAELGYAELDDRSSRLAALLAARGVRRGDVVAVAVPRSAALTVALLAALKAGAAYLPVETDYPAERIAYVLGDARPAVLVTTSQALAALPEEIKGTVRSLVVLDDLGTDWELAAVAAEEIRALPGPLPQSPAYVIYTSGSTGRPKGVVVPHRGIVNRLLWMQDTYRIGADDRVLQKTPSGFDVSVWEFFWPLVAGSTQVAARPGGHRDPAYLARLVQESGITTVHFVPSMLEVFLAEPEAARCTGLRRVLCSGEALPAGLRDRFRAALGGVELHNLYGPTEASVDVTAWDCATAADTASVPIGRPVWNTRTHVLDAALNPAPTGSSGELYLGGVQLAHGYLNRPDLTAERFVADPYGPPGSRLYRTGDLARVTRDGVIEFLGRTDDQVKIRGQRIELGEIEHALTRHPRVGSAVVTAHRDESGDTRLAAYVTVTDPAAPVEPEELRDLLAALLPDHMVPVHYAVIDAVPVTPNGKVDKKALPAPRLLDRRPGRAPRDENETALCEIFAELLGHDTVHIDDNFFELGGHSLLATKLISRVRDRLGAELSVVSIFEAPTVATLAGRLGRDATTGPTSPLLTLRPGGTDTPLFCVHPLGGLSWPYASLAEHLPTEVGLHGLQAVGLDGDEPLPETLQEMADDYVARVRSVQPEGPYRLLGWSLGGRIAHAMAERLEAAGQEVELLALLDAYPSTTVDTDARFSEREFLDGILSAAGLDASALDGPVDIDTVMAAVRSTGDDLAGLTADQLRRLQRVMANSFRLDGAARTGRCRAGAVMFAATVDPAGDPDHWHGHVDGGLEIHTVAVGHNDLMRPEPLAEIGAVLAKKLARTSGA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	340.29	gnl|BL_ORD_ID|4935|hsp_num:0	5928			90	1629	colistin A; colistin B
BGC0001297.1|WS9326_22 # 27812 # 35542 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.751	BGC0001297.1|WS9326_22 	27812	35542	-	Loose	1000	144.05	almE	27.95	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCACCGAGCCCTCGTCGCTGGAAGCCGTCCTGCCGCTCACCCCGCTGCAGGAGGGCCTGCTCTTCCACGCGCAGTACGACGAGCAGGACGGCCCGGACGTCTACGTCATGCAGCTCGGCATGGACATCGACGGACCGCTCGACGTCCCCGCCCTGCGCTCCGCCGCCCGCGTCCTGCTCCAGCGGCACGGCAACCTGCGCGCGGGCTTCCGCGACGGCGGCGCGCGGCCCCTGCAGTTCGTCCCGAAGCAGGTCGACCTGCCCTGGCGGGACGTCGACCTGAGCGAACTGCCCGAGGAGGAGCGGGAGGCGGCGCTGCGCGAGGTCACCGAGCGCGACCGGGCCGCCCGCTTCGACCTGCACCACCCGCCGCTGCTGCGGTTCACCGTGGTGCGCACCGCGCCGCTGCGGCACCGGCTGCTGGTCACCAACCACCACATCCTGCTCGACGGCTGGTCGGCGCCGGTCCTGGTGCGCGAACTGTTCGAGCTGTACGCGGCCGGCGGTGACGCCGCGGCCCTGCCCCCGGTGACACCGTTCCGCTACCACCTGGGCTGGCTCGCCAAGCAGGACCGCGACGCCGCCGGCCGGGCCTGGCGGGACGCGCTCGCCGGGCTCGACGGGCCGACCCTGCTGGCCGCCCTGCCCGACGACCGCTCCGCCTCCGTGCTGCCCAGCAAGGTCGCCGCGACGCTGTCGCCGGAGACCACCGAGCGGCTCAACCGGCGCGTGCGCGAACTCGGCCTCACCCTGAACACCGTCGTGCACGCCGCCTGGGGCCTGCTGCTGGGCCGGCTGACCGACCGCACCGACGTCACCTTCGGCATGACCCTCGCCGGCCGGCCGCCGGAGATCCCCGGCGTGCACACCATGGTCGGCCTGTTCCTCAACACCGTGCCGGTCCGGGTGCGCCTGGAGCGCGACGAGACGCTCCTCGCGCTGTGCCGGCGGCTCCAGGACGAGCAACGTGCCCTGATGGCCCACCAGTTCCTCGGCCTCGCGGAGATCCAGCGCACCGCCGGGCACGGCGACCTGTTCGACACCCTCACCGTGACGGAGAACTTCCCCGTCGACCCGGCCGCCCTCGACCTGCCCGGCGGACTGTCGGTCGCCGGGGTCTTCTCCACCGACGGCGCGCACTACCCGCTCGCCCTCATGGTCATCCCCGGCGACTCGCTCGAACTGCGCTTCACCTACCGCGCCGACGCCTTCGACGAGGCCCGCATCGAGAGCTACAGCCGCGCGCTGACCGCCGTACTGGAGGCCTTCGTCGCCGACCCGTCCGTCCCGGCGGGCACCGTCGACGTCCTGGACACCGCCGTACGGTCCCGGCTGCTGGAGGAGTGGAGCCCGCAGCCCGCACCCGCCGCCGCGCACACCCTGCCCGAACTGCTCGCCCTGCGCACCGCCGAGACACCCGACCGGGAGGCCCTGGTCTGCGGCGGCCTCTCGCTGACCTACGCCGAACTCACCGACCGGGTCGAGCGGATCGCGGCCTGGCTGCGCGAGCGCGGCGTGCGCGACGAGGAGCCCGTCGGCATCGCCATGGACCGCTCCGCCGAGTACGTCCTCGCCGTGCTCGGCGTGATCCGCGCCGGCGCCGTGTACGTACCGGTCGACCACCGCTGGCCGGCGGCCCGGCGCGAGCACGTCCTCGGCGACAGCGGCATCCGGCTGATCCTCGAACAGGGCGACCTGCCCGAGGACCACCCGCTGCCCGAGGGCGGCGTCCCGATGCCGCCCGGACCCGACCGGATCGCGTACATCATGTACACCTCCGGCTCGACCGGCCGCCCCAAGGGCGTCGCCGTCACCCACCGCGGCATCGCCGACCTCGCCGCCGACGGCCTGTTCGCGGGCGGCGCGCAGGAGCGCGTGCTGCTCCAGTCGGCGCACGCCTTCGACGCCTCCACCTACCAGATGTGGATCCCGCTGCTGAACGGCGGCACCCTCGTCGTCGGACCGCCCGGTGACCTGGACATCGCCACCATCGGCCGCACCCTCGTCGAGGGCCGCGTCACCGCCACGCTGTTCACCACCGGCCTGTTCCGGCTGATCGCTGCCGAGGCCCCGGAGACGTTCCGGTCGCTGCGCGAGGTGTGGACCGGCGGCGAGGCCCTGCCCGCCGCCGCGGTCCGCCAGGCCCTGGAGGCCTGCCCCGACCTGACGGTCGTCAACGCCTACGGGCCCACCGAGGTCACCGTCATGGCCGCCGCGCACCGGCTGCCGGCCGGCGAGCCCGTACCGGAGCCGGTGCCCATCGGCCGTCCCCTCGACGGCAAGCGCGTCCTGGTCCTCGACAGCGGCCTCAGGCTGTGCCCGCCCGGCGTCGCCGGCGAACTGTACGTCGCCGGTGTGGGACTGGCCCGCGGCTACGTCGGCCGGCCCGACCTGACCGCCGAACGGTTCGTCGCCGACCCCTACGGCGAGCCCGGCGCCCGCCTGTACCGCACCGGCGACGTGGTGCGCTGGCGCGAGGACGGCCTGCTGGAGTTCGTCGGCCGCACCGACAACCAGGTGAAGCTGCGCGGCTTCCGCATCGAACTCGGCGAGATCGAGGCCGTACTGGCCGGACACGACGCCGTCGGCCAGATCGCCGTCGTCGTCCGCGAGGACCGGCCCGGCGTGCGCCACCTCGTCGGCTACGCCGTCCCGGCCGCCGGCGCGACCCTGGACACCGAGGAGCTGCGCACCTGGGCCGCCGAGCGGCTGCCCGACTACATGGTGCCCCGGCCCCTCGTCGCCCTGGACGCGCTGCCGCTGACCACCAACGGCAAGCTGGACGTGCGGGCCCTGCCCGCGCCCGAGCACACCGAGGAGGAGACCCGCGGCCCGCGCACCCCGCACGAGGAACTGCTGTGCGGACTGTTCGCCGAGGTCCTCGGCCGCGAGACGGTCTCCGTGCACGACAACTTCTTCGAGCTGGGCGGCCACTCGCTGCTCGCCACCCGCCTGGTCAGCCGCGTCCGTTCGGTGCTCGGCGTCGAACTGCCCATCCGCCGCGTCTTCGAGGAGCCGACGGTCGCCGCGCTCGCCGCCCGGCTCACCGACACCCCGGCGGCCGCCCGGCCCGCGCTGCGACCGGCCGACCGGCCGGAGCGGGTGCCGCTGTCCTTCGCGCAGCGCCGCCTGTGGTTCCTCAACCGCATGGAGAGCTCCACGTACAACCTCCCGCTGGCCGCGCGGCTGAACGGGCCGATCGACGTGGTCGCCCGGCACGAGGCGCTGCGCACCGTGTTCCCGGACAGCGACGGAGAGCCCTGGCAGCAGATCCTGCCGGCCGGGCACGCCGTCGTGGACATCGAGGTCTCCGACGTCACCGAGGCCGGACTGCCCGCCGCCCTGCACGCGGCCGGCACGGCAGGCTTCGACCTCGCCGTCGACCTGCCGGTGCGCGCCTGGCTGTTCCGCCTCGCCCCCGACGAGCACGTGCTCTGCGCGGTCGTGCACCACATCGCCGGCGACGGCTGGTCCCAGGCGCCGCTGGTCCGCGACCTGTCGGCGGCCTACCGGGCCCGCCTGGAAGGCACCGCGCCGGACTGGCGTCCGCTGCCGGTGCAGTACGCCGACTACGCCCTCTGGCAGCGCGAACTGCTCGGCGACGAACAGGCCGACGACAGCACGGCCGCCACCCAGCTGGCGTACTGGAAGGAGCGGCTCGCCGGCGCGCCGCAGGAACTCCAGCTGCCCACGGACCGGCCCCGCCCGGCCGTCGCCGGACACGAGGGCGGCACCGTGCCGGTGCACGTCGACGCCGCACTGACCGGCGCGCTGCGCGAGCTGGCCGCGAAGACCGACACCACGCCGTTCATGGTGTTCCAGGCCGCGCTGGCCGCGCTGCTGTCCCGGCTCGGCGCCGGCGACGACATCCCGATCGGCACCCCGGTCGCCGGCCGCACCGACGCCGCCGCCGACGACCTGATCGGCTTCTTCGTCAACACGCTGGTGCTGCGCACCGACGTCTCCGGCGACCCGAGCTTCACCGAACTGCTGCGCCGGGCGCGCGCGGCGGCGCTGGGCGCCTACGCCCACCAGGACCTGCCGTTCGAGCGGCTGGTCGACCTGGTCGGCGCCGACCGCTCGCTGTCGCACAACCCGCTGTTCCAGGTGATCCTCGCCTACCAGAACAACGACCTGCGCGCGGTCGAGCTGCCCGGCCTGGAGGTCACCCCGCACGAGATGCTGCTGCCGGTCGCCAAGGTCGACCTGGAACTCACGCTGGTCGAGGACACCGCCGGCGGCGGCATCTCCGGCCTGCTGAACTACGCCACCGACCTGTTCGACCGCGACAGCGCCGAGCGCGTCGCCGCCCACCTGGTGGCGCTGCTGCGGGCCGCCGTCGCCGAACCGGCCCGCCCGGTGCGGACCCTGGAGATCCTGCCGCCCGCCCAGCGCGAGCAGTTGCTCACCGGCTGGAACGACACCAGCCGGCCGGTACCCGCGGGCACCGTCCCGGAGCTGTTCGCCGCGCGCGCCGCCGCCCACGCCGACCGCCCCGCCGTCGTCTGCGAAGACGGCGAGCTGGACTACGCCACGCTGGCCGACCGGGCCAACCGGCTCGCCCGGCTGCTGATCGAACGCGGCGCGGGACCCGAGGACCGGGTCGCGCTGGTCCTGCCGCGCTCCGCGGACCTCACCACCGCGCTGCTCGCGGTGATGACGGCGGGCGCCGCCTACGTGCCCGTCGACCCGCACCACCCGGCCGACCGCATCGAGTACATGCTCACCGACGGCGACCCGGTGCTCGTGGTCACCCTCACCGCGCTGGCGGACCGGCTGCCCGACCAGATCGCCGAACCGGTGTTCCTGGACAGCCCCGACGTCGTCCGGGCCCTCGCCGGCCACTCCGGCGCCGAGCTCACCGACGCCGACCGCCGGTCCCCGCTCAGCCCCGACCACCCGGCCTACGTCATCTACACCTCCGGCTCCACCGGCCGCCCCAAGGGCGTCGTCGTCGGCCACCGCGGCCTGGGCAACCTCGCCGCCTGGCAGGCCGGCCACCTCGGCGTGACCGCGGACAGCCGCATCGGGCAGTTCGCCGCGCCGAGCTTCGACGCCGCCGCCTGGGAGACGGTGATGGCGCTGCTCAACGGCGCCACCCTGGTGCTCACCCCCGCCGACGGCCCGGTCCTCGGCGACGCCCTCACCGCCTTCCTGCGCGAACGGGCCGTCACCCACGCCACCCTCACCCCGACCGCCCTGTCCGGCGCCGACCCGCAGTCCGCGCCCGACGGCCTGACCCTGGTCCTCGCCGGCGAGGCCGTCCCGCGCGACCTGGTGGCCCGCTGGGCGCCCGGCCGCCGCGTCGTCAACGCCTACGGCCCCACCGAGACCACCGTCTGCGCCACCGCGTCCGGACCCGTCGACGGCTCCGTCACCCCGCCCATCGGCGGGCCCATCGCCAACACCCGGGTCTACGTCCTGGACGGTGCGCTCAACCTGTGCCCGGTCGGTGTCGCGGGCGAACTGTACGTGGCGGGCACCGGACTGGCGCGCGGCTATCTGCGCCGGCCCGGTCTGACCGCGGAGCGGTTCGTCGCCGACCCGTTCGGCGAGCCCGGCGCCCGGCTGTACCGCACCGGCGACGTGGTGCGGTGGCGGGCCGACGGCGCACTGGAGTTCGTCGGCCGCCGCGACAACCAGGTCAAGCTGCGCGGCTTCCGCATCGAACTCGGCGAGATCGAGGCGGCGGTGGCCGGCTGCGCCGGCGTGGACGCGGCGGCCGTCGTGGTCCGCGAGGACCGGCCCGGCGTACGGCAGCTGGTGGCGTACGTGGTGCCCGACGGCGACGCCGAGTGCGCGCCGGAGACGGTGCGCGCCCACGCGGCCGAGCGGCTGCCGGAGTACATGGTGCCGCAGGCGGTCGTCGTCCTGGACGCGCTGCCGCTGACCGTCAACGGCAAGCTGGACCAAGCGGCGCTGCCCGCACCGGAGTTCGGCGGCGACGACGGCGGCCGGGCGGCGACGACCGACGCCGAGAAGATCGTCGCCGAGGCGTTCCGCGAGGTGCTGGGACTGCCCGAGGTGAGTGCCGACGCCGGCTTCTTCGAACTCGGCGGCGACAGCATCGTCTCCATCAAGCTGGTCGGCGAGGTCCGCAAGGGCGGCCTGGTCATCACGCCCCGGGACGTGTTCGAGCACAAGACGGTCGCCGGTCTGGCGGCCGTCGCCCGCAGCGCGGACGACCTGCCCGAGCAGGACCCGGACGCCGGCATCGGCGAGGTCCCGCTCACCCCGATGACACACTGGCTGCGCGAACTGGGCGGCCGCACCGAACGGTTCCACCAGTCGGTGCTGCTGCGGGTGCCCGCCGGACTCGGCCGGGAGCGGCTGACCACGGCCGTGCGCACCGTGCTCGACCACCACGACGCGCTGCGGCTCACCCTGTCCGACACGGCGGGCCAGTGGTCGTACGAGGTCAGGCCGCGCGGCGCGGTGGACGCCGACGGCTGCGTCACCCGGGTCGACGTCACCGGCGCCGGGACCGAGGAGCTGCGCGCCGCGATCGCCGAGCACGCCGAGCGGGCCGTCGGCCAACTGTCGCCCACGGACGGCGAGATGGTGCGCGTGGTGTGGTTCGACGCCGGCCCGGACGCGCCGGGCAGGCTGCTGCTCGTCGCGCACCACCTGGTGGTCGACGGCGTGTCCTGGCGGATCCTGGTGCCCGACCTGGCCGCCGCCTGGCAGGCCGCCGCGTCGGGCGCCGAGCCCGCGCTCGAACCGGTCGGCACCGCGTGGCGGCGCTGGGCCCAGTGGCTCGGCGAACTGGCCGCGCAGCCCGCCCGCGCCGCACAGGTCGCCTGGTGGGCGGACCAACTGCGCGACGAGGACGTCCTGGTCACCGCCGAGCGGCGCGACCCGGCCGTCGACACCATGGCCACCCAGAGCGCGCTCGCCGTCACCCTGCCCGAGGACGTCACCGGCCGGCTGCTGACCGCCGTACCGGCAGCGGCGCGCTGCGGCGTGGAGGACGTGTTCCTGACGGCGTTCGCCCTCGCCGTCGCCGACTGGCGCAGGCGGCGCGGACTCGGCGCCGGCACCTCCGTCCTGGTCGACGTCGAACGGCACGGCCGGCAGATCCCGCCCGGTCACGACCTCGACGTCTCCCGCACCGTCGGCTGGTTCACCAGCCTCGCCCCGGTGCGCCTCGACCTCGGCCCGGTCTCCTGGGGCCAGGTGTTCACCAGCTCCGCCGCCCTGCACAAGGCGCTCTCCCGGGTCAAGGAGACCCTGCGCGAGATGCCCGACGAGGGCATCGGATACGGCCTGCTGCGCCACCTCAACCCGCGCACCCGGGACGAACTGGCCGCCTACGAGCAGCCCCAGTTCGGCTTCAACTACCTGGGCCGCACGGCCGTCGCCGACGCGGACGCCGGCGACGCGCGGACGGGTGACGACTGGAGCATGTCCGCCGACGGCGAGGTGCTGCGCGAACTGGGCGGCGGAGACCCGCAGATGCCGGCCCCGCACGCGGTCTCCCTCAACGTCGTCGTCGAGGACGGCCCGGCCGGGCCGCGCCTGGTCGCCAACTGGACCTGGCCGCGCCGCCTGCTGGAGCCCGACGAGCTGCGCCGGCTGGCCGACGGCTGGTTCCGCGCGCTGACCGCGCTCGCCGACCACGCCGCCGAGGAACAGCCCACCGGCCTCACCCCCTCGGACCTGTCACTGATCGACCTCGAACTCGACGACCTCGGGGTGCTGGAAGCAGAGTGGAGGAAGACCCAGTGA	MSTEPSSLEAVLPLTPLQEGLLFHAQYDEQDGPDVYVMQLGMDIDGPLDVPALRSAARVLLQRHGNLRAGFRDGGARPLQFVPKQVDLPWRDVDLSELPEEEREAALREVTERDRAARFDLHHPPLLRFTVVRTAPLRHRLLVTNHHILLDGWSAPVLVRELFELYAAGGDAAALPPVTPFRYHLGWLAKQDRDAAGRAWRDALAGLDGPTLLAALPDDRSASVLPSKVAATLSPETTERLNRRVRELGLTLNTVVHAAWGLLLGRLTDRTDVTFGMTLAGRPPEIPGVHTMVGLFLNTVPVRVRLERDETLLALCRRLQDEQRALMAHQFLGLAEIQRTAGHGDLFDTLTVTENFPVDPAALDLPGGLSVAGVFSTDGAHYPLALMVIPGDSLELRFTYRADAFDEARIESYSRALTAVLEAFVADPSVPAGTVDVLDTAVRSRLLEEWSPQPAPAAAHTLPELLALRTAETPDREALVCGGLSLTYAELTDRVERIAAWLRERGVRDEEPVGIAMDRSAEYVLAVLGVIRAGAVYVPVDHRWPAARREHVLGDSGIRLILEQGDLPEDHPLPEGGVPMPPGPDRIAYIMYTSGSTGRPKGVAVTHRGIADLAADGLFAGGAQERVLLQSAHAFDASTYQMWIPLLNGGTLVVGPPGDLDIATIGRTLVEGRVTATLFTTGLFRLIAAEAPETFRSLREVWTGGEALPAAAVRQALEACPDLTVVNAYGPTEVTVMAAAHRLPAGEPVPEPVPIGRPLDGKRVLVLDSGLRLCPPGVAGELYVAGVGLARGYVGRPDLTAERFVADPYGEPGARLYRTGDVVRWREDGLLEFVGRTDNQVKLRGFRIELGEIEAVLAGHDAVGQIAVVVREDRPGVRHLVGYAVPAAGATLDTEELRTWAAERLPDYMVPRPLVALDALPLTTNGKLDVRALPAPEHTEEETRGPRTPHEELLCGLFAEVLGRETVSVHDNFFELGGHSLLATRLVSRVRSVLGVELPIRRVFEEPTVAALAARLTDTPAAARPALRPADRPERVPLSFAQRRLWFLNRMESSTYNLPLAARLNGPIDVVARHEALRTVFPDSDGEPWQQILPAGHAVVDIEVSDVTEAGLPAALHAAGTAGFDLAVDLPVRAWLFRLAPDEHVLCAVVHHIAGDGWSQAPLVRDLSAAYRARLEGTAPDWRPLPVQYADYALWQRELLGDEQADDSTAATQLAYWKERLAGAPQELQLPTDRPRPAVAGHEGGTVPVHVDAALTGALRELAAKTDTTPFMVFQAALAALLSRLGAGDDIPIGTPVAGRTDAAADDLIGFFVNTLVLRTDVSGDPSFTELLRRARAAALGAYAHQDLPFERLVDLVGADRSLSHNPLFQVILAYQNNDLRAVELPGLEVTPHEMLLPVAKVDLELTLVEDTAGGGISGLLNYATDLFDRDSAERVAAHLVALLRAAVAEPARPVRTLEILPPAQREQLLTGWNDTSRPVPAGTVPELFAARAAAHADRPAVVCEDGELDYATLADRANRLARLLIERGAGPEDRVALVLPRSADLTTALLAVMTAGAAYVPVDPHHPADRIEYMLTDGDPVLVVTLTALADRLPDQIAEPVFLDSPDVVRALAGHSGAELTDADRRSPLSPDHPAYVIYTSGSTGRPKGVVVGHRGLGNLAAWQAGHLGVTADSRIGQFAAPSFDAAAWETVMALLNGATLVLTPADGPVLGDALTAFLRERAVTHATLTPTALSGADPQSAPDGLTLVLAGEAVPRDLVARWAPGRRVVNAYGPTETTVCATASGPVDGSVTPPIGGPIANTRVYVLDGALNLCPVGVAGELYVAGTGLARGYLRRPGLTAERFVADPFGEPGARLYRTGDVVRWRADGALEFVGRRDNQVKLRGFRIELGEIEAAVAGCAGVDAAAVVVREDRPGVRQLVAYVVPDGDAECAPETVRAHAAERLPEYMVPQAVVVLDALPLTVNGKLDQAALPAPEFGGDDGGRAATTDAEKIVAEAFREVLGLPEVSADAGFFELGGDSIVSIKLVGEVRKGGLVITPRDVFEHKTVAGLAAVARSADDLPEQDPDAGIGEVPLTPMTHWLRELGGRTERFHQSVLLRVPAGLGRERLTTAVRTVLDHHDALRLTLSDTAGQWSYEVRPRGAVDADGCVTRVDVTGAGTEELRAAIAEHAERAVGQLSPTDGEMVRVVWFDAGPDAPGRLLLVAHHLVVDGVSWRILVPDLAAAWQAAASGAEPALEPVGTAWRRWAQWLGELAAQPARAAQVAWWADQLRDEDVLVTAERRDPAVDTMATQSALAVTLPEDVTGRLLTAVPAAARCGVEDVFLTAFALAVADWRRRRGLGAGTSVLVDVERHGRQIPPGHDLDVSRTVGWFTSLAPVRLDLGPVSWGQVFTSSAALHKALSRVKETLREMPDEGIGYGLLRHLNPRTRDELAAYEQPQFGFNYLGRTAVADADAGDARTGDDWSMSADGEVLRELGGGDPQMPAPHAVSLNVVVEDGPAGPRLVANWTWPRRLLEPDELRRLADGWFRALTALADHAAEEQPTGLTPSDLSLIDLELDDLGVLEAEWRKTQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	463.31	gnl|BL_ORD_ID|4935|hsp_num:0	5928			111	1629	colistin A; colistin B
BGC0001297.1|WS9326_23 # 35546 # 43249 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=3bp;gc_cont=0.742	BGC0001297.1|WS9326_23 	35546	43249	-	Loose	1000	143.28	almE	28.11	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTCTGACTCGTCAGCCACGGTTCTGCCACTGACCGCCGGCCAGGCCGGAATCTGGTACGCACAGAGCCTGAGCGGCCCCAACGCCACCTTCAACGCGGCCCTCTACCTGGACATCGAAGGAGCGGTGGACGAGCGGCTGTTCGTCGCCGCGATGCGCCAGGTCGTCACCGAGGCCGAGGCCCTGCGGGCCCGGATCACCGACGACGGCACCGGCCCGGTGCAGGTCCTCGAGCCCGTCGGCGACTGGGCCGAGCAGCCCGTGCAGGTCGTGGACTTCACCGCGGCCGAAACGCCGTGGCAGGACGCCGAGGCGTGGATGTGGGCCGACGCCGGCACCCCGCTCGACATGAGCGGCGAGCCGCTGTACCGGTTCGCCCTGCTGAAGGTCGCCGACGACCGGTCGCTGTTCTACTACCGCTACCACCACGTGGTGATGGACGCCGCCGGCGCGAGCCTGGTCGCCGCCCGCGTCGCCGACGTCTACACCCGGCTCGTCGCCGGTGAGGACACCGCCGACGGAGCGTTCCCGCCGCTGCGCGAGCTGATCGAGGACGAGGCCGCCTACCGGCGGTCCGCCGCCTTCGAGGCCGACCGGGAGTACTGGACCGCGCGGTTCGCCGACACCCCGGCCGTCCCGAGCCTCGGCGACCGGCCCACCGCGATGCCCCACCACCAGCTGCGCGGCGGCGCCCGCGTCCCGGCCGCCGTCGCCGCCGAGGTCCGCGACGCGGCCCGCACCGTCGGCGTCGGCTGGCCGGCCGCCGTACTGGCCGCGCTGGCCGCCTACACCAGCCGCATCACCGGCAGTTCGGACGTGGTGGTCGCGCTGTCCGTGGCCGCCCGCACCACCGCCGCCGGCCGCGCCGTGCCCGGCATGGTCTCCAACGTCATCGGCGTCCGCCTGGACGTGCGGCCGGAGATGACGGCCGCCGAACTCATCCGGCACGCCCACCTGAGGATGCGCGAGGCGTCCCGGCACAAGCGCTACCGCTACGAGGACCTGCGCCGCGACCTGAAGCTCCTCGGCTCCGACGGCCGGCTGCTCGGCCCGCGCCTCAACCTGCACGTGGCCTCCGCCGCCGTGGAGTTCGCCGGCGTCCCCGCCACCCTGCACCCGCTCACCGCCGGCCAGGACGACGACTTCTCCCTGATCGTGATGGCCGAGCCGGACGGCGGCTTCCGCTTCGACATGACGGCCAACCCGGACGTCTACCGCTCCGGCGCCGCCGAGCGCCACCACCGCCTCGTCATGCGGCTGCTCGGCGAACTCGCCGCCCGCCCGCACCGCCCGGTCGGCGCGTTCGACACGGTGGACGACGAGCTGCGGACCCGGCTCGTGAACGACTGGGGCGGCGTGAACGCCACGGCCGCCGCCCCGGAGCAGGTGCTGTCGACCCTGACCGAACGTTTCGCCGAGGCGGCCGCCGCCCACCCCGACCACACGGCCGTCGTCGCCTTCGACGGCGACGACCGCCGCACCCTGACCTACCGGGAACTCGACGAGCGCTCCAACCGCCTGGCCCGCCTGCTGATCTCGCGCGGTGTGCGGCGCGGCGACCTCGTCGCGCTGGCCATGCCCCGCTCGGCGGACCTGCCCGTGGCGCTGCTCGCCACGGTCAAGGCCGGCGCGGCCTACCTGCCGATCGACCCCGACTCCCCGGCCGACCGGGCCGCCTACATCCTCGGCGACGCCCGCCCGACCGCCATGGTCACCGCCCACCAGGACACCCTGGCGGCCCGCCCCGACGGCGACGTCCCCACGATCGTGCTGGACGACCCGTTCATCCGCATCGCCCTGGCCGCGCTGTCCGACGCGCCCGTCGAGGACGGCGACCGGGGCGGCCCGCTCCTGCCGCACCAGGCCGCCTACGTCATCTACACGTCCGGCTCCACCGGCCGCCCCAAGGGCGTCGTCGTCGCCCACCAGAACGTGATCCGGCTGCTCGACCGGACCCGCCACTGGAGCGGCTTCGGCCCGGACGACGTGTGGGCGCTGTTCCACTCCTACGCCTTCGACTTCTCCGTGTGGGAGATCTGGGGCGCCCTGCTGCACGGCGCCGGACTCCTGGTCCCGCCGCACCACGTGACCCGCTCCCCGCACGAGTTCCTGCGCATGCTGGCCCGCGAACGGGTCACCGTGCTCAACCAGACGCCGTCCGCCTTCTACCAGCTGATCCAGGCCGACGCCGACGAACCGGACACCGGCGCCGAACTCGCCCTGCGCTTCGTGATCTTCGGCGGCGAGGCCCTGGAGTTCGGCCGCCTCGCCCAGTGGTACGAGCGGCACGCCGAGGACGCGCCGCGGCTGGTGAACATGTACGGCATCACCGAGACCACGGTGCACACCACCGAGCTGATGCTGAACGCCGCCGACGCCACCGCCGGCACCGGCAGCATGATCGGCCTCGGCATCGGCGACCTGCGCCTGTACGTCCTCGACGGCGCGCTGCGCCCGGCCCCGCCCGGCGTCCCCGGCGAGCTGTACGTCAGCGGCCCCGGCGTCGCCGACGGCTACCTGGGCCGGCCCGACCTGACCTCCACCCGCTTCGTCGCCGACCCCTTCGGCCCCGCCGGGCAGCGCATGTACCGCTCCGGTGACGTGGTGCGCTGGGCCGAGGACGGCAGCGCCAACCTCGAGTACCTGGGCCGCTCCGACCACCAGGTCAAGATCCGCGGCTTCCGCATCGAACCCGGTGAGATCGAGTCCGCCGTCCTGCGCCACCCCGACGTGCGCCAGGCCGCCGTCGTCGTGCGCGAGGACACCCCCGGCGACAAGCGCCTGGTGGCGTACGTCGTCGGCGGGCAGGGCGGCGAGGCCGCCGCGCTGGAACCGGCGGCCCTGCGCAAGCACGCCGCCGCCGAACTGCCCGACCACATGGTGCCGTCCTGGTTCGTGCAGTTGGACGCGCTGCCGCTGACCACCAACGGCAAGCTCGACACCCGGGCCCTGCCCGCGCCCGACTTCGGCGCCGGCGTCTCCGGCCGCGCCCCGCGCACCCCCGAAGAGGAGATCTTCTGCGGCTTGTTCGCGGAGATCCTGGGCCTGCCGTCGGTCTCCCTGGACGACAACTTCTTCGACCTGGGCGGCCACTCGCTGCTCGCCACCCGGCTGGTCAGCCGCATCCGCGCCGCGTTCGGCGTGGAACTGGCCATCCGCACCGTCTTCGAGCAGCCCACCCCGGCCGCGCTGATCGGCTGGCTGGCCGGCACCGGCAACCTGCCCGAGGCGCGGCGCCCGCTCACCGTGATGGACAAGCCGGAGGAGATCCCGCTGTCCTTCGCGCAGCTGCGGCTGTGGTTCGTCGACAAGATCGACGGCGGGGCCGGCACGTACAACATCCCGCTCGTGGTGCGGCTGCTCGGCGCGCTCGACGAGGAGGCGCTGCAGGCCGCGATCGGCGACGTGATCGCCCGGCACGAGAGCCTGCGCACCGTCTTCCCCGACCGGGACGGCACCCCGCGCCAGCACATCCTGTCCGCCGCCGAGGCCACCCCCGTCATGGGCGTGACCGAGATCGCCGCGGACGAACTGGCCGACGCCATGGCCGACATGGCCGCCATCGGCTTCGACCTGGCCACCGAGGCCCCGGTGCGCGCCCACCTCTTCCGCGTCGCCGAGGACGACCACGCGCTGCTCATGCCGGTGCACCACATCGCCGGCGACGGCTGGTCCCTGGTGCCGCTCACCCGCGACCTGGAGACCGCCTACACCGCCCGCAGCCAGGGCCGGGTCCCCGACTGGAAGCCGCTGCCGGTGCAGTACGCGGACTACACGCTGTGGCAGCGCGAGATCCTCGGCGACGAGGACGACCCGAACTCCGCCATCCGCGCCCAGCTCGCGCACTGGAAGCAGTACCTGGCCGGGCTGCCCGAGGAGGTCACCCTCCCCACCGACCGGCCCCGGCCGGCCGTCGCCTCCTACCGCGGCGAGACCCTGCGCTTCGCGCTCACCCCCGAGCAGTACCAGCAGCTGATGCGCTGCTCCCGCGAGTTCGACGTCAGCCCGTTCATGGTGGTGCAGACCGTGCTGGCGGCGCTGCTGAGCAAGCTCGGCGCCGGCGACGACATCCCCCTCGGCATCTCCATCGCGGGCCGCACCGACGAGGCGCTGGACGACCTGGTCGGCTTCCTCGTCAACACCCTCGTGATGCGCACCGACCTCAGCGGCGACCCCCGCTTCGACGACCTGCTCGGCAAGGCCCGGGTGGACGGCCTGGCCGCCTTCGCCAACCAGGACCTGCCGTTCGAGCGGCTGGTCGAGGCCGTCAACCCGGAGCGGTCCGCCGGCCGCCACCCGCTCATCCAGATCGGCCTCGGCTTCCAGAACAACGCCACGCCGACCCTCGACCTGCCCGGCCTCGACGCGTGGATCGAGCCGGCCGTCACCCGCACCGCCAAGCTGGACCTGCTCTTCGACTTCCGCGAGGTGCAGGGCGAGGGCGACGGCCCCGACCACATGGTCTGCGCCGTCGAGTACGCGACCGACCTGTACGACCGCTCCACCGTGGAACTGCTCGTCGAGCGGCTGGTGCGGCTGCTGGACGCGGCGACGGCCCGGCCGGCCGCCCGGCTGAGCGAGCTGGACGTGCTCCGCGACGACGAGCGCCGGCGCGTCCTCGTCGAGTGGAACGACACCGCGCGCGCCGTCGACTTCGACACCCTGCCCGCCCTGTTCGCCGCCCAGGTGGCCCGTACGCCCGAGGCGCTCGCGCTGGTCGCCGGCGCCGAGGAGCTGTCGTACGCCGAGCTGGAGGTGCGGGTCAACCGGCTCGCCCGGCAGCTCGTCGCGCGGGGGATCGGCGCGGAGGACCGCGTCCTGCTGGTCATGCCGAAGTCCGTCGACCTGGTGGTGGCGCAGCTCGCCGTGGTCACCGCGGGCGCCGCGTTCGTGCCGGTCGACCCGGCCTACCCGCGCGACCGTGTGGCGTTCATGGCGCAGGACTGCGCGCCCGCGCTGATGCTGACCCGCACGGACGTCGCGGAGACGGCCGCCGAGGTCGTCCCGGACACGCCGACGCTGGTGGTCGACGACCCGGCCACCGCCGCCGAGATCGCCGCCCGGCCCGACACCCGGCTCACCGACGCCGAACGGGTCCGTCCCGCCTCGGTCGACCACGCCGCCTACGTCATCTACACCTCCGGCTCGACCGGCCGGCCCAAGGGCGTCGTCGTCACCCACCGCGGCATCGGCAACCTGGCCGCCGCGCAGATCGAGCGGTTCGCGATCCGGCGCGACAGCCGGGTCGTGCAGTACGCCACGCCGAGCTTCGACGCGGCCGTGTCCGAGACCTGCATCGCCCTGCTCCGCGGCGCCGCGCTGGTCCTGCCCGTCGACACCGGGCTGCTGCTCGGCGACGCCCTCGCCCGGTTCCTCACCGAGTACCGCGTCACCCACGCCACCATCCCGCCGGTCGCGCTGACCGGCCTGGACCCGGCGGCCGTGCCCGCGGACCTGGTGCTCACCGTCGCCGGCGAGGCCTGCCCGGCGGAACTGGCCGGCATCTGGTCCCACGGCCGCCGCATGATCAACGCCTACGGCCCCACCGAGACCACCGTCTGCGCCACCATGAGCGAGCCGCTCACCGAAGCGGCCGTCCCGCCCATCGGCACCCCGATCACCAACATGCGGGTGTACGTGCTCGACTCCCGGCTCAGCCCGGTCCCGCCCGGTGTCGACGGCGAACTGTACGTCGCCGGTGTCGGCCTGGCCCGCGGCTACCTGGGCCGGCCCGGACTGACCGCCGAGCGGTTCGTCGCCGCGCCGTTCGGCGAGCCGGGCGAGCGGATGTACCGCACCGGTGACGTGGTGCGCCGCCGCGCCGACGGGCAACTGGAGTTCGTCGGCCGCGCCGACGACCAGGTCAAGCTGCGCGGCTTCCGCGTCGAACCCGACGAGATCGCCGGTGTCCTCACCGACCAGCCGCAGGTCGCGTCGGCGGCCGTCGTCATCCGCGAGGACCGGCCCGGTGAGCGCAGGCTCGTCGGCTACGTCGTGCCCGCCCGGCAGGCCACCGAGGGACGCGACACCGGACTGGAGACCGACCAGGTCGACAAGTGGCAGGTCATCAACGACGAGGTGTACGGCGCCGCCGACGAGGCGGACGGCCCGCCGCTCGGCGAGAACTTCGCCGGCTGGCACAGCAGTTACGACGGCTCGGTGCTGCCCGAGGAGGAGATGCGCGCCTGGCGCGCGGCCACCGTCGAGCGGATCCTGGACCTGCGGCCGAAGCGGGTGCTGGAGATCGGCGTCGGCGCCGGCCTGATCATGGCGCCGGTCGCCCCGCACGTGGAGCTGTACTGGGGCGCCGACCTGTCCGGCACGGTCATCGAGACCCTGCGCCGGCAGACCGCCGCCGACCCGGTGCTGGCCGACCGCACCCGGTTCACCGCCGCCCCGGCGCACAGCCTGGACGGCGTGCCGGAGGGCACCTTCGACACCGTCGTCATCAACTCCGTGGCGCAGTACTTCCCGAGCGTCGACTACCTGACCGAGGTCATCGCCAAGGCGTTCGCGCTGCTCGGCGACACCGGCGCGGTCTTCCTCGGCGACCTGCGCGACCTGCGGCTGCTGCGCTGCATGCGGGCGGGCGTCCACCGCGTGGCGCACCCCGGCGACAGCCCCGCCGCCGCGCGCGCCGCCGTCGACCGGGCCGTCGAGCGGGAGACCGAACTGCTCGTCGACCCGGGCCTGTTCGACACCCTCGCCGGCACCCTGGACGGCTTCGGCGGCGTCGACATCCGCATCAAGCAGGGCGCCTACGACAACGAGCTGAGCCGCTACCGCTACGACGTGGTGCTGCACAAGCGCCCGGCGGAAGCCGTCTCCCTCGCCTCGGTGCCCGTCCTGGCCTGGGACGACGCCGGCGGCCTCACCGGGCTCGCGACCAGGCTGCGCGAGAGCGCCGCCGGCCCGCTGCGCGTCACCGGCATCCCCAACGGGCGCCTCGCCGCGGACCTGGTGGCCGTCGCCGAGATCGACGGCGTACCGGCACCCGACGGCATCGCCGTGGGCGCGCTCACCGACATCGGCTCCCGCGCCGGCTACCGCACCCTGGTCACCTGGACCGCCGCGGCCGCCGACGGCCGGCTGGACGCCGTGTTCGTCCCGGCCGGCGCCGGCGAGGAACCCGAGCCCGCCTACCGGGACCTGTACCTGCCGGGCCCGGCCCCCGAGCGGTACGCCAACGACCCGCTCGCCGGCCGCAAGGACGGCGCCCTGGTCGCCGAGCTGCACGACGCGCTCGCCGCCCGCCTGCCCGACTACATGGTGCCCGCCGCGCTGGTCGTCCTCGACGCGCTGCCCGTCACCCCGAACGGCAAGCTCGACCAGAAGGCGCTGCCCGCCCCGGACGCCGCCGCCTCCGCCTCGCACCTGGCACCCGCCACACCGGAGGAGGAGACCATCGCCCGGATCTTCGCGGAGGTGCTCGGGCTCGCCCGGGTCGGCGCCGACGACGACTTCTTCCGCCAGGGCGGCGACAGCATCGTCTCCATCCAGCTGGTCAGCAAGGCCCGGGCGGCCGGACTGACCCTGACCGCGCAGGACGTCTTCGCCCACCGCACCGTACGGGCCATCGCCGCGGCGGCCACGCCCGCACCCGACGACACCGGCACGACCGACCAGGCGGCCGGCAGCGAGTGGGACATCCCCCTGGTCTCCCAGGACGAGCTGGACGAGTTCGCATCGAATTGGAGCGTTTAG	MSDSSATVLPLTAGQAGIWYAQSLSGPNATFNAALYLDIEGAVDERLFVAAMRQVVTEAEALRARITDDGTGPVQVLEPVGDWAEQPVQVVDFTAAETPWQDAEAWMWADAGTPLDMSGEPLYRFALLKVADDRSLFYYRYHHVVMDAAGASLVAARVADVYTRLVAGEDTADGAFPPLRELIEDEAAYRRSAAFEADREYWTARFADTPAVPSLGDRPTAMPHHQLRGGARVPAAVAAEVRDAARTVGVGWPAAVLAALAAYTSRITGSSDVVVALSVAARTTAAGRAVPGMVSNVIGVRLDVRPEMTAAELIRHAHLRMREASRHKRYRYEDLRRDLKLLGSDGRLLGPRLNLHVASAAVEFAGVPATLHPLTAGQDDDFSLIVMAEPDGGFRFDMTANPDVYRSGAAERHHRLVMRLLGELAARPHRPVGAFDTVDDELRTRLVNDWGGVNATAAAPEQVLSTLTERFAEAAAAHPDHTAVVAFDGDDRRTLTYRELDERSNRLARLLISRGVRRGDLVALAMPRSADLPVALLATVKAGAAYLPIDPDSPADRAAYILGDARPTAMVTAHQDTLAARPDGDVPTIVLDDPFIRIALAALSDAPVEDGDRGGPLLPHQAAYVIYTSGSTGRPKGVVVAHQNVIRLLDRTRHWSGFGPDDVWALFHSYAFDFSVWEIWGALLHGAGLLVPPHHVTRSPHEFLRMLARERVTVLNQTPSAFYQLIQADADEPDTGAELALRFVIFGGEALEFGRLAQWYERHAEDAPRLVNMYGITETTVHTTELMLNAADATAGTGSMIGLGIGDLRLYVLDGALRPAPPGVPGELYVSGPGVADGYLGRPDLTSTRFVADPFGPAGQRMYRSGDVVRWAEDGSANLEYLGRSDHQVKIRGFRIEPGEIESAVLRHPDVRQAAVVVREDTPGDKRLVAYVVGGQGGEAAALEPAALRKHAAAELPDHMVPSWFVQLDALPLTTNGKLDTRALPAPDFGAGVSGRAPRTPEEEIFCGLFAEILGLPSVSLDDNFFDLGGHSLLATRLVSRIRAAFGVELAIRTVFEQPTPAALIGWLAGTGNLPEARRPLTVMDKPEEIPLSFAQLRLWFVDKIDGGAGTYNIPLVVRLLGALDEEALQAAIGDVIARHESLRTVFPDRDGTPRQHILSAAEATPVMGVTEIAADELADAMADMAAIGFDLATEAPVRAHLFRVAEDDHALLMPVHHIAGDGWSLVPLTRDLETAYTARSQGRVPDWKPLPVQYADYTLWQREILGDEDDPNSAIRAQLAHWKQYLAGLPEEVTLPTDRPRPAVASYRGETLRFALTPEQYQQLMRCSREFDVSPFMVVQTVLAALLSKLGAGDDIPLGISIAGRTDEALDDLVGFLVNTLVMRTDLSGDPRFDDLLGKARVDGLAAFANQDLPFERLVEAVNPERSAGRHPLIQIGLGFQNNATPTLDLPGLDAWIEPAVTRTAKLDLLFDFREVQGEGDGPDHMVCAVEYATDLYDRSTVELLVERLVRLLDAATARPAARLSELDVLRDDERRRVLVEWNDTARAVDFDTLPALFAAQVARTPEALALVAGAEELSYAELEVRVNRLARQLVARGIGAEDRVLLVMPKSVDLVVAQLAVVTAGAAFVPVDPAYPRDRVAFMAQDCAPALMLTRTDVAETAAEVVPDTPTLVVDDPATAAEIAARPDTRLTDAERVRPASVDHAAYVIYTSGSTGRPKGVVVTHRGIGNLAAAQIERFAIRRDSRVVQYATPSFDAAVSETCIALLRGAALVLPVDTGLLLGDALARFLTEYRVTHATIPPVALTGLDPAAVPADLVLTVAGEACPAELAGIWSHGRRMINAYGPTETTVCATMSEPLTEAAVPPIGTPITNMRVYVLDSRLSPVPPGVDGELYVAGVGLARGYLGRPGLTAERFVAAPFGEPGERMYRTGDVVRRRADGQLEFVGRADDQVKLRGFRVEPDEIAGVLTDQPQVASAAVVIREDRPGERRLVGYVVPARQATEGRDTGLETDQVDKWQVINDEVYGAADEADGPPLGENFAGWHSSYDGSVLPEEEMRAWRAATVERILDLRPKRVLEIGVGAGLIMAPVAPHVELYWGADLSGTVIETLRRQTAADPVLADRTRFTAAPAHSLDGVPEGTFDTVVINSVAQYFPSVDYLTEVIAKAFALLGDTGAVFLGDLRDLRLLRCMRAGVHRVAHPGDSPAAARAAVDRAVERETELLVDPGLFDTLAGTLDGFGGVDIRIKQGAYDNELSRYRYDVVLHKRPAEAVSLASVPVLAWDDAGGLTGLATRLRESAAGPLRVTGIPNGRLAADLVAVAEIDGVPAPDGIAVGALTDIGSRAGYRTLVTWTAAAADGRLDAVFVPAGAGEEPEPAYRDLYLPGPAPERYANDPLAGRKDGALVAELHDALAARLPDYMVPAALVVLDALPVTPNGKLDQKALPAPDAAASASHLAPATPEEETIARIFAEVLGLARVGADDDFFRQGGDSIVSIQLVSKARAAGLTLTAQDVFAHRTVRAIAAAATPAPDDTGTTDQAAGSEWDIPLVSQDELDEFASNWSV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	461.69	gnl|BL_ORD_ID|4935|hsp_num:0	5928			156	1629	colistin A; colistin B
BGC0001297.1|WS9326_25 # 44845 # 44952 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=8bp;gc_cont=0.722	BGC0001297.1|WS9326_25 	44845	44952	+	Loose	300	21.1718	tet(32)	50.0	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGTGGTCGTCCTCAACGACTCGCCCACCGGCGCCGACGCCGACGACGCCCGCAAGGTCGCGGAGCACCTCTGCCCGGGCAAGGCCGTCCTGATCACCGGCGGCTGA	MVVVLNDSPTGADADDARKVAEHLCPGKAVLITGG	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	5.48	gnl|BL_ORD_ID|1220|hsp_num:0	1233			912	948	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001297.1|WS9326_26 # 45060 # 45857 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.749	BGC0001297.1|WS9326_26 	45060	45857	+	Loose	600	26.1794	vanJ	36.47	3002914	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanJ membrane protein	ATGACTCAGCTCAGCGGATGGAAAGTGCTCGGCCCCGGCCGGGCCGGCGGCGAGCTGGTGCTCGCCGTCGACTTCGCCACCACCGGCCGGTCCGACTCGGCCTTCACCGACCTCGCACCGCGCCTCGACCCGGAGCTCGCCGTGTGGGAGACCCGCCAGCCGGCCGGCGACGGCCTGCCGGCCGAGGACTACCTCGCGCTGTGGGACGGCGAGGCGGCGGCCGACGGCCGCAGGGTGCGGGCCGTGCTCGGCTACTGCGCCGGCAGCGTGTTCGCCGGTGAGCTGGCCGCGCGGGTCGCGGCCCGGCAGGACGAGGCCCCGCACCTGGTGCTGTTCGAGCCGGAGGTGCCCGAACCGGCGGGCCTGTACCGGGACTTCGCCGCGATGATGAACCAGTTCGCCTCGGTGCTGACCGCCGAGGAGGTGAGCGCCGCGCAGCAGGAGGCGGACGCCGCCCGCACCGGTGACGTGGACTTCGGCGCGTACGGCGACGTCCTGGTGCGGATCTTCATGGAGCGGGCCGGTGCGGCGTTCGCCCGGGAGGAGCTGGACACCGAGCTGCTGGACGAGTTCGTCGCGGTGTTCCGGTCGTACGTCTCCTACCTGGACGCCGCCCGCCGCATCGACCCGGCCGCCGCGTGGCGCACCGCGACCGCGGTCGGCTCCCGCACGCCGTCGCAGGGCGCGGCGCTGGCCGGCCGGAACGTCGGCATCGACGTCGACCACTGCGACATGCTGCGCGACAAGCGGGTGGCGGAGGCCGTCAACCGGATCCTCGGCTCCCGCGTGGCGTCCTGA	MTQLSGWKVLGPGRAGGELVLAVDFATTGRSDSAFTDLAPRLDPELAVWETRQPAGDGLPAEDYLALWDGEAAADGRRVRAVLGYCAGSVFAGELAARVAARQDEAPHLVLFEPEVPEPAGLYRDFAAMMNQFASVLTAEEVSAAQQEADAARTGDVDFGAYGDVLVRIFMERAGAAFAREELDTELLDEFVAVFRSYVSYLDAARRIDPAAAWRTATAVGSRTPSQGAALAGRNVGIDVDHCDMLRDKRVAEAVNRILGSRVAS	MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGVSW	80.30	gnl|BL_ORD_ID|2036|hsp_num:0	2240			189	423	teicoplanin
BGC0001297.1|WS9326_27 # 45928 # 46872 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.743	BGC0001297.1|WS9326_27 	45928	46872	-	Loose	750	25.409	LRA-10	26.6	3002489	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase	ATGACCGGGCCCGCCGCCGTGCCCCGCGCCTACGCGGCACCGCTGCGCGCGGTGGACCGGACGGAGACCGTCTCCGACGGGCCCGTGACGCGGCTCGTGCTGTACAAGACCGTCGACCCCGAAGACCCCTACATGGCCGGTCACTTCCCGGGGCTGACGCTGCTGCCGGCCGTGTTCGTCCTGGAGGCGCTGCGCCAGGCGGTGACCGACCTGACCGGCGCGGACGAGCCGCTGAACCTGCTGGAGGTGAGGTCGGGGCGCTGGCTGGCGCCGATGCAGGGCGGTGACGAGATCCGCCTGGACGTCACGGTGACGCCCGACGGGCCCGGACGCCTGACGGTGACCGCCGACGGCGTACGGCAGGACGGCACGCCCGTCGCGGCGGTGAAGGCGACGCTCGGCGACCGCGCGGCCGTCCTCGCCGCGCGGCCCCCCGAGGACCCGCCGCCCGCCCCGGCCGACGGCCCGCCCGGACCCGACTACACCGGCATCCTCGGCCTGCTGCCGGTACGGCACCCGATGCTGATGGTGGACCGGGTCGAATCCCTCGACCCGGGACGGCAGATCACCGTCGCCAAGGCGGTCTCCGGATCCGAGCCCTGCTACCAGGACCTGGCCGACGGACTGCCCCTGTCGCGGTACATGTACCCGCGGTCCCTGATGCTGGAGTCGTTCGGGCAGGCCTCGGTGCTGCTGTGGCTGGCCACCGGCACCGCCGAGGGTGTGCCCGTGGCCGCCGCCTTCCGCGACTGCCGCTTCTTCGGCGAGGTGCGGCCCGGCGCCGTACTGCGGCACGTGTCGCGGATCGACCGGCTGATGGCGAACAACGTGTTCGTCTCCGGGCAGACCTGGGACGGCGACCGGTGCGTGATGACGGTCGGCACCCTGGTCGGCTCCAGCCGGCCCCGCGAACGCGTCGACCGCGCGCTGACCACCGCCTCCTGA	MTGPAAVPRAYAAPLRAVDRTETVSDGPVTRLVLYKTVDPEDPYMAGHFPGLTLLPAVFVLEALRQAVTDLTGADEPLNLLEVRSGRWLAPMQGGDEIRLDVTVTPDGPGRLTVTADGVRQDGTPVAAVKATLGDRAAVLAARPPEDPPPAPADGPPGPDYTGILGLLPVRHPMLMVDRVESLDPGRQITVAKAVSGSEPCYQDLADGLPLSRYMYPRSLMLESFGQASVLLWLATGTAEGVPVAAAFRDCRFFGEVRPGAVLRHVSRIDRLMANNVFVSGQTWDGDRCVMTVGTLVGSSRPRERVDRALTTAS	MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYGVASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKATLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLALKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIRSTAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQAGNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIPGPDRIKAAHAILEQL	83.73	gnl|BL_ORD_ID|1915|hsp_num:0	2119			654	933	
BGC0001297.1|WS9326_28 # 46869 # 47291 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.730	BGC0001297.1|WS9326_28 	46869	47291	-	Loose	1800	25.7942	mdtC	36.17	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAGCACCACCACCGCCGCCGGCCGAGGCTCCGGACCGCCCGTGCTGTGCGTCCTGGACCGCGCCTACCGGGGCGCGGTCGAGGCGCAGTTCTTCCACGCCCTGTACGGACTGCTCGACCTGCACGGCCAGTTCCAGCGGGTGGACGTGGCGCTGCGCGGCGCCGCGGTGACCCTCGCCGTCGAGGAGGACGTCTACCGGCCCTCGGTCCGGCTCGGCACGATGACCCTGGACACCCTGCCCGACTACCGCGGCTCCGTGCGCGACCTGGTCGCCGAGGACTTCACCGTCTTCGTGGACCGGGACGCCGTGACGGCGCTGGGCTTCGACCCGCAGCGGCTCGTCGCCGGGACCGTCCTGCTCGACCCGGCCGAACTCGCGCTGCGCTGGCCCGAGTACGACCAGGTGTGGTTCGTATGA	MSSTTTAAGRGSGPPVLCVLDRAYRGAVEAQFFHALYGLLDLHGQFQRVDVALRGAAVTLAVEEDVYRPSVRLGTMTLDTLPDYRGSVRDLVAEDFTVFVDRDAVTALGFDPQRLVAGTVLLDPAELALRWPEYDQVWFV	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	13.66	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2025	2163	novobiocin
BGC0001297.1|WS9326_29 # 47291 # 47701 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.727	BGC0001297.1|WS9326_29 	47291	47701	-	Loose	500	30.0314	linG	27.71	3002879	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGGCCCGCATGGAACGCCGCGTGTGGGACCTGCTGCTGATCCTCACCGCGGCCCCGCACTCCGGGGACGTGGTGACCTCGGCGCTGCGCCTGTCCCAGGCGGTGCTCGACCGGGGCGGCTCGGTACGGGTCTGGGCGTGCGGCTACGCCAACATGATGACCCAGGACACCTTCGGCGACACCAAGCTGCCCAACACCCGTGACCCCGAGGGCCACTACCCGTCCCCGTCGGCCGTCGTGCAGCGGATGATCGCCGACGGCGACGGCCGCTTCGGGTGGATCGCGTGCACCGCCTGCTCCGAGGAGCGCGGCGCCGTGCACCACGTGCCGCAGGTACGGCACCGCTCCCCGCTGCGGCTGGCGACGACCATCGCCGGTGCCCGGCAGACGCTCTACCTCGGAGGGGCCTGA	MARMERRVWDLLLILTAAPHSGDVVTSALRLSQAVLDRGGSVRVWACGYANMMTQDTFGDTKLPNTRDPEGHYPSPSAVVQRMIADGDGRFGWIACTACSEERGAVHHVPQVRHRSPLRLATTIAGARQTLYLGGA	MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDRSGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLELFKSVTEPLNIELPRTVIAQAKRLLNESATPHNK	49.82	gnl|BL_ORD_ID|1730|hsp_num:0	1873			450	675	lincomycin
BGC0001297.1|WS9326_33 # 49778 # 50782 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=8bp;gc_cont=0.773	BGC0001297.1|WS9326_33 	49778	50782	+	Loose	700	25.409	FOX-4	41.18	3002158	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	ATGACCGCCGTACTGATCACCGGCGTCGGCGCCGTCGCCGAGGAGCCGCGTACGGACGGGGACCCGGGCCCGTGGTTCGACCCGGCCGCCCATCTCGGCCGGCGCGGCTGGAAGTACTTCACCCCGGCCACCCGTTACCTGCTGGCGGCCGCGAACGAGGCGCTCGGCCGGCGCCACGACGACCCGCCGCCGGCCGGCGTCGCCGCCGAGCGGTTCGGTGTGGTGACCGGCACCCAGTACGCGATCGCCCGGGTGCACCGCCGGATGGACACCGTCCTGACCGGCGAGGGCGTGCACGGCATCAGCCCCGCCGAGGTGCCGGGCTTCTCCATGAACACGCCCGGCAGCCAGCTGGCCATCAGCACCGGCGCCCGCGCCTTCTCGGTCACGCTCACCAATCCGGTGACCGCGGGCCTGGAGGCCGTGCAGTTCGCGGTGACCGCGCTGCGCACCGGGCGGGCCGACGTGGTGGTGGCGGCCGCGGCCGACCAGGCACCCGAGGACCACGGCGCCCGCGGCGAGTACGACGCCGCCGCGGCCGTCGTCCTGTCGGCGGGGGGACGCGCTTCCGGCACGGCAGGCGCCACCCGTCCCCTCGCCACGGTCACCGGCGCGCTGTCCCGGTTCCTGGCACCGGGACCCGCCGGTGACCTGGCCCCCGCGGCGCTCGACCGGAGCGCCGCGCGCGTGGCCGCGCTGGCCCCGTCGCCCGGCGGAACGGATGCCGTGCGCCTGCTGGTCGGCGCGCCGCCGGCCGCCGCCCCGCACGCGGCGGCGGTCCGCGACGCCGTGGCCGAGGCCCTCGCCGACCGCGGTGTCCCGGTGCGGGACGCGGACGCCGGCGGGACGCGGCCGGCCCGGCACTGCGCGGTGTCGGGGCTGCTGGACCTGATCGGGCCGGCCCGGGCGGGCGAGACCGCCCTGGTGCTGTCCATTTCCGAACTCGGGCATCTCACCGCAATAGGAATCCACCGCGCCGATCCCGTTGGTCCAGAATTCATCTGA	MTAVLITGVGAVAEEPRTDGDPGPWFDPAAHLGRRGWKYFTPATRYLLAAANEALGRRHDDPPPAGVAAERFGVVTGTQYAIARVHRRMDTVLTGEGVHGISPAEVPGFSMNTPGSQLAISTGARAFSVTLTNPVTAGLEAVQFAVTALRTGRADVVVAAAADQAPEDHGARGEYDAAAAVVLSAGGRASGTAGATRPLATVTGALSRFLAPGPAGDLAPAALDRSAARVAALAPSPGGTDAVRLLVGAPPAAAPHAAAVRDAVAEALADRGVPVRDADAGGTRPARHCAVSGLLDLIGPARAGETALVLSISELGHLTAIGIHRADPVGPEFI	MQQRRALALLMLGSLLLAPCTYASGEAPLTATVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGSAFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRATPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFHSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	87.43	gnl|BL_ORD_ID|1581|hsp_num:0	1726			645	747	
BGC0001297.1|WS9326_34 # 50852 # 51811 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.703	BGC0001297.1|WS9326_34 	50852	51811	+	Loose	500	26.1794	APH(6)-Ib	37.14	3002658	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGACAGTAAGGGCAGAACAGCCGACCGACCGATTGACCAGGTTTCGCCGAGTCGGCGGCCTCGGAGCAGCCATAGCGGTGACACCGTATCTGCTCATCAAAATCGTCTGGACTTTCGGTTTTTTCATTCCGACCGAGGAAATGGGCGGCGCCGACTGGCGGGCGATCAACGCGGCGACCGCGTTCCTCGCCGCCGTCGGCATCGTGCTGGCGATGGCGTTCTCCCGGCCCTGGGGCGAGCGCCTGCCCGCCTGGCTGGTGGCGCTGCCCGTGTGGGTGGGCACCGGTCTGCTCGTGCCCATGCTGCTGCTGGCGCCGGTGCTCGGCCCGGCCGCCATGAACCGCGACCAGGACGCCGGTTCACCGGACTTCTGGATCTACGAACAGATCCTCGTGATGATCTCGCTGGTCGGCGTCGGCGTCGGCCTGCCCCTCGCCCTCGCCGGCTACGCCAAGGCCCGCTGGCCGGAGGCCCTGGGCGGTCCGCTGGCGTTCGACGAACCGGTGGGCGGCACCCGGCAGTTGCAGGTGACGCTGGCCCGGCTGGTCGCGGCCGGCTGCGTCCTGCTCGCCTGCGTGAAGGTGTTCTGGGCGGCGGGCGGCACCCTCGGCCTGGACGCCGACCAGTTGGACCGGCGTGACCTGTGGTGGCACATGCTGTCGCTGAGCACGGCCGTCTGGGCGCTCGCCGGGGCCTGGGGCATCCTCGTGCTGACCGCCCGCCGCGGCACCAACCGGTTCCTCCCGCCGATGATCGCCGCCTGGGTGTCGTCGGGCATGCTGTTCTCGTACAGCGTCTACAACCTGCTCACCCTCACCGACATGCAGCAGCCCTCCCCCGAACTCCCGCTTGCGGGAGCCCTGGCGAGGGATGTCAGCGCGGTGCTCGGCGTGATGATGGGGATGACCCTGCTGCTGGTCCTGCACGACCGCCGGCGCGCCCTGCGGCCCGGCGACTGA	MTVRAEQPTDRLTRFRRVGGLGAAIAVTPYLLIKIVWTFGFFIPTEEMGGADWRAINAATAFLAAVGIVLAMAFSRPWGERLPAWLVALPVWVGTGLLVPMLLLAPVLGPAAMNRDQDAGSPDFWIYEQILVMISLVGVGVGLPLALAGYAKARWPEALGGPLAFDEPVGGTRQLQVTLARLVAAGCVLLACVKVFWAAGGTLGLDADQLDRRDLWWHMLSLSTAVWALAGAWGILVLTARRGTNRFLPPMIAAWVSSGMLFSYSVYNLLTLTDMQQPSPELPLAGALARDVSAVLGVMMGMTLLLVLHDRRRALRPGD	MSTSKLVEIPEPLAASYARAFGEEGQAWIAALPALVEELLDRWELTADGASASGEASLVLPVLRTDGTRAVLKLQLPREETSAAITGLRTWNGHGVVRLLDHDPRSSTMLLERLDASRTLASVEDDDAAMGVLAGLLARLVSVPAPRGLRGLGDIAGAMLEEVPRAVAALADPADRRLLNDWASAVAELVGEPGDRMLHWDLHYGNVLAAEREPWLAIDPEPLAGDPGFDLWPALDSRWDDIVAQRDVVRVVRRRFDLLTEVLGLDRARAAGWTYGRLLQNALWDIEDGSAALDPAAVTLAQALRGH	103.91	gnl|BL_ORD_ID|811|hsp_num:0	880			3	108	streptomycin
BGC0001297.1|WS9326_35 # 51908 # 52654 # -1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GGCGG;rbs_spacer=7bp;gc_cont=0.743	BGC0001297.1|WS9326_35 	51908	52654	-	Loose	450	27.7202	ermZ	28.09	3004605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCACCGGCCCCGGCCGCGGCCGCACGCCGAACGGGTGCTGGTGTGCCTCAGCTACTGCGGCGGCGGCACCGCGCCGTTCCGGCAGTGGGCCAACGTGCTGCCGGACGATGTCGAACTGGCGCTGATCTGCTACCCGGGACGCGAGGCCCGGTTCGGCACGCCGTTCGCGCGGGTCTGGACGGATCTGCGGGACGACGTGGTGCGGGCCGTGCGCGGCCTCACCGGGCGCCCCTACATCCTGTTCGGGCACAGCATGGGCTCCTGGGTGGCGTTCGAGACCGTGGCGGAACTCGAACGGCTGGGCGTCGCGCCGCCCGAGGCGCTCGTGGTGTCCGGCGGTGTGGCCCCGCACCGGCGCCGGGAGGTGCCCGCCGAGGCCGTACCGCGCTCCGACGACTCCGCGGAGGCGCTGGTGCGGTGGATGCGGGACCTCGGACAGGTCTCGCCGGCGATCGCCGCCGAACCGGAACTGGTCAAGATCGCGGTGGACCTGCTCCGCGCGGACCTCGCGGTCTCGGAGTCCTACCGCTTCGTGCCGGGCTCACGGGTCTCGGTGCCGCTGCGGGTGCTGTACGGGACCGAGGACGTGGCGCCGTTCGCCGACGTCGAACGGCACTGGCGTCCGCTGACCGACGGCGCCTTCCAGGCCGTGGAACTGCCCGGCGGGCACTTCTACACACCGGAGGTGTGGTCCAGGCTGCCCGAGTGGTGCACCCTGCCCGTGCCCGGCGCCGCCGCCCGCTGA	MHRPRPRPHAERVLVCLSYCGGGTAPFRQWANVLPDDVELALICYPGREARFGTPFARVWTDLRDDVVRAVRGLTGRPYILFGHSMGSWVAFETVAELERLGVAPPEALVVSGGVAPHRRREVPAEAVPRSDDSAEALVRWMRDLGQVSPAIAAEPELVKIAVDLLRADLAVSESYRFVPGSRVSVPLRVLYGTEDVAPFADVERHWRPLTDGAFQAVELPGGHFYTPEVWSRLPEWCTLPVPGAAAR	MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMTVEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVRLIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFDRGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARKVLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR	87.94	gnl|BL_ORD_ID|225|hsp_num:0	3303			501	756	spiramycin
BGC0001297.1|WS9326_36 # 52701 # 52919 # -1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.676	BGC0001297.1|WS9326_36 	52701	52919	-	Loose	400	24.6386	Plasmid-encoded cat (pp-cat)	32.61	3002689	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAGCACCAATCCTTTCGAGGACAACGACGCCCAGTACCGCGTGCTGGTCAACGACGAGGGGCAGCACTCGCTGTGGCCGGCGTTCGCCGAGGTCCCGGCGGGCTGGACGGTGGCGCACCCCGAGGACAGCCGCCAGGCCTGCCTCGACTACGTCAACGAGAACTGGACCGACATGCGTCCGCTCAGCCTGGTGCGCCAGATGGAAGGCGCCAAGTAG	MSTNPFEDNDAQYRVLVNDEGQHSLWPAFAEVPAGWTVAHPEDSRQACLDYVNENWTDMRPLSLVRQMEGAK	MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFIHILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDIACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA	32.88	gnl|BL_ORD_ID|1355|hsp_num:0	1342			147	282	azidamfenicol; chloramphenicol; thiamphenicol
BGC0001297.1|WS9326_37 # 52967 # 53230 # -1 # ID=1_37;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.648	BGC0001297.1|WS9326_37 	52967	53230	-	Loose	550	53.1434	NmcR	43.08	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	GTGCTGATCGCGGAAACCGGGCGCATGGATGTCGCGGCGCGGAAACTGGGTTATTCCCAGCCGGCGATCACCTATCAGGTTCAGCGACTTGAGCAGTCTCTCGGCTTCAAACTCTTCACCCGGCATCCCAGCGGTGCCCGGCTGACGGGGAACGGGCGGATGATCCTGCCGTCCGTGCGTGCGGTGCTTCTGCTGATCGACAGCATGCGGGACGCGCACGGTTCGGGAGCCGGTGAGGACCGGGACCTGGAGTGCAGCGCCTGA	MLIAETGRMDVAARKLGYSQPAITYQVQRLEQSLGFKLFTRHPSGARLTGNGRMILPSVRAVLLLIDSMRDAHGSGAGEDRDLECSA	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	29.49	gnl|BL_ORD_ID|1905|hsp_num:0	2072			72	267	cefoxitin; cefazolin; ampicillin
BGC0001297.1|WS9326_38 # 53526 # 54161 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=14bp;gc_cont=0.700	BGC0001297.1|WS9326_38 	53526	54161	-	Loose	390	55.0694	evgA	23.44	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGGCCGAGGACTCGACCCTGCTGCGGGAAGGGCTGGTCCGACTGCTCGCCGAGGAGGGCCACGAGGTCCTCGCCGCGGTCGGTGACGCCGTCGCCCTGCTGCGGGAGGTGGAGGCGCGGCCGCCGGACCTGGTCGTCGTCGACATCCGGATGCCTCCCACCCACACCGACGAGGGACTGCGGGCCGCGCTGGAGATCCGCGAACGGTGGCCCGAGATCGGGGTCCTGGTGCTGTCGCAGCACCTGGAACGCGCCTACGCGGCGCAACTGCTCACCTCGAACGCGGAGCGCGTCGGCTATCTGCTCAAGGACCGGGTCGCCCAGGTGGAGGAGTTCCTCGACGCCCTGGAACGCATCCGGGCCGGTGGCGCCGCCATCGACCCCGAAGTCGTACGGCAGTTGGTGGTCCGCACCACGCACAGCGACCCGCTGGCCCGGCTGACGCCGCGCGAGCGCAGCGTCCTGGAGGCGCTGGCCGAAGGGCACACCAACGCGGCCATCGCGGAGAAGCTGCACATCTCCATGAGCACGGTGGAGAAGAACCTCAACACGATCTTCGACAAGCTCGAACTCGCCCGCACCACCGGCTCCAACCGGCGCATCCTGGCCGTCCTGCGCTACCTGGAGTCCTAG	MLAEDSTLLREGLVRLLAEEGHEVLAAVGDAVALLREVEARPPDLVVVDIRMPPTHTDEGLRAALEIRERWPEIGVLVLSQHLERAYAAQLLTSNAERVGYLLKDRVAQVEEFLDALERIRAGGAAIDPEVVRQLVVRTTHSDPLARLTPRERSVLEALAEGHTNAAIAEKLHISMSTVEKNLNTIFDKLELARTTGSNRRILAVLRYLES	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	103.43	gnl|BL_ORD_ID|936|hsp_num:0	1015			9	564	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001297.1|WS9326_30 # 47701 # 48072 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.755	BGC0001297.1|WS9326_30 	47701	48072	-	Loose	1400	23.0978	Acinetobacter baumannii parC conferring resistance to fluoroquinolones	50.0	3003818	protein variant model	D105E	n/a	fluoroquinolone antibiotic	antibiotic target alteration	fluoroquinolone resistant parC	ATGGAGGCGCAGACGGCGGCCACCGGCACCACCGCCGGTGCCGGCGCCGCGTCGTACTTCCTGGTCGAGAGCAAGGGCAACTGGGCGGGCCCCAACGCGGCCGCGTTCCTCGCGGACGCCGCGGCGCTCGCCGAGGCCGGCCACCGGGTACGGGTGTTCCTCGTCGAGGACGGCGTACTGAGCGCCGTCGGCACCGACGTCCCCGAGATCCGGCGGCTGGCCGAGGCCGGCGCCGAGATCCTCGTGGACGACTTCTCGGCGGCGCAGCGCGCGCTGTCCGCCACCACCCTGTCGCCGCACGTCAGGATCGCCGGCATGGACCTCGCCGCCGCCGCGCTCACCGAGGACGGCTGCCGGGGAGTGTGGCACTGA	MEAQTAATGTTAGAGAASYFLVESKGNWAGPNAAAFLADAAALAEAGHRVRVFLVEDGVLSAVGTDVPEIRRLAEAGAEILVDDFSAAQRALSATTLSPHVRIAGMDLAAAALTEDGCRGVWH	MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKSSGKPKKSARTVGDVLGKYHPHGDLACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFAAMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGMATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGRGSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTRLVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKKTVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEAILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIIGELKEDAKKFGDERRSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAVGKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIAASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDLAELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRASKGQLLPRGYQKANKLLIQR	16.64	gnl|BL_ORD_ID|2112|hsp_num:0	2315			300	342	enoxacin; ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; lomefloxacin; nalidixic acid; norfloxacin; ofloxacin; trovafloxacin; grepafloxacin; sparfloxacin; pefloxacin
BGC0001297.1|WS9326_32 # 48540 # 49781 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.791	BGC0001297.1|WS9326_32 	48540	49781	+	Loose	750	99.3673	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.53	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGACGGTGGTGGTCACGGGACTCGGTGCGGTGAGCTGCTTCGGCAGCGGCACCGGCGCCCTGTGGGAGGGGCTGCTCGGCGCGAGCCGGCGGCCGGACCCCGCACCGGACGTCTGCGGCCTGCCGGCCCGCCCGCACCTGTACGCGGTGCCGGACGGCGACGCCCCGGCGCGGGGCACCGGGCGGACCGGCGCGCTGCTGGCGACCGCCGTCGCCGAGGCCGTCGCGGAGGCCGGGCTGAGTGCCGGTGACCTGCTGGACGCGGGACTGACCGTGGGGACGTCGCTGGGCGACATCGACCTGTCGGAACCGGGCGTGGGCGCGGGCGCGGCTGCCGGGGCCGGTGCGGACGCGCGTCCGGGCGCCGGAGCGGCTGCCGGGACCGGTCCGGGCACGGGCCCGGGGCCGTTCGGGGACGCCGTCGGCGTTCCGCCCGCCACGCACCGGGTGGCGGCCTCGCTCGCGACCCGGTTCGGCATCGGCGGACCCGGCCAGACCCTCTCCACCGCCTGCTCGGCGGGCGCCTACGCGGTGGGCTGGGGCGCGGAGCTGATCGAGACGGGACAGGCGGACGTCGTCGTGGCGTGCGGCGGGGACGCCTTCTCCCGCGTCGCCGTCGGCACGCTCCAGCGGTTCGGACTGCTGGACGGCGAGTGCTGCCGGCCCTTCGACACCGGCCGGGCGGGCATGGTCACCGGTGAGGGCGCCGCCGCCCTGGTGCTGGAGTCCGCCGAGTCCGCCCGCCGGCGCGGCCGGCCCGTGCACGCGGTGCTGGCCGGACACGGCTGGAGCTGCGACGCCCACCATCCGATGGCGCCGGAGCCGTCCGGCGAACAGTTGCGCCGCTCGGCCGCCCGGGCCCTCGCCGGGATCGACGGCACGCCGGGCGCGGCCGTGCTGCACCGCGCCGGAGTGGCGGTCAACGACACCGTGGAGGCCGCCGCGATCAGCGCGGCCGTCGAGGCCGCCGGCGGGTCCGGCGGCGACGTGCTCGGCTACGCGCCCAAGGCGGTGATGGGCCACACGGCCGGCGCGGCCGGCGTGTTCGGCTGCGTGATCGCGGCCCTCGTCCTGCGCCACGGCCTGGTCCCGCCCAACGCGCACGTCACCGACCTCGACCCGGACTGCCCGCTGACGGTCCCCCTGGACCGGCCGGCCCCGCTCGCCCGGCCCTCGGTCCTGGTGAGCGGCACCGGCTTCGGCGGCAACAACGCCGTACTGACCTGGCGGGCCGCCGCATGA	MTVVVTGLGAVSCFGSGTGALWEGLLGASRRPDPAPDVCGLPARPHLYAVPDGDAPARGTGRTGALLATAVAEAVAEAGLSAGDLLDAGLTVGTSLGDIDLSEPGVGAGAAAGAGADARPGAGAAAGTGPGTGPGPFGDAVGVPPATHRVAASLATRFGIGGPGQTLSTACSAGAYAVGWGAELIETGQADVVVACGGDAFSRVAVGTLQRFGLLDGECCRPFDTGRAGMVTGEGAAALVLESAESARRRGRPVHAVLAGHGWSCDAHHPMAPEPSGEQLRRSAARALAGIDGTPGAAVLHRAGVAVNDTVEAAAISAAVEAAGGSGGDVLGYAPKAVMGHTAGAAGVFGCVIAALVLRHGLVPPNAHVTDLDPDCPLTVPLDRPAPLARPSVLVSGTGFGGNNAVLTWRAAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	99.28	gnl|BL_ORD_ID|1968|hsp_num:0	1943			504	1239	isoniazid
